- Professor, Public Health
- Associate, Center for Toxicology
- Director, Biometry Shared Services
- Professor, Statistics-GIDP
- Teaching Award
- MEZCOPH, Spring 2015
No activities entered.
Biostatistics/ResearchBIOS 576B (Spring 2019)
Intro Statistical Analysis SASBIOS 504 (Spring 2019)
Intro to Statistical AnalysisBIOS 503 (Spring 2019)
Biostatistics/Pub HealthBIOS 576A (Fall 2018)
Independent StudyBIOS 599 (Fall 2018)
Intro Statistical Analysis SASBIOS 504 (Fall 2018)
Intro to Statistical AnalysisBIOS 503 (Fall 2018)
Master's ReportBIOS 909 (Fall 2018)
Biostatistics/ResearchBIOS 576B (Spring 2018)
Intro Statistical Analysis SASBIOS 504 (Spring 2018)
Intro to Statistical AnalysisBIOS 503 (Spring 2018)
Master's ReportBIOS 909 (Spring 2018)
Biostatistics/Pub HealthBIOS 576A (Fall 2017)
Intro to Statistical AnalysisBIOS 503 (Fall 2017)
Biostatistics SeminarCPH 696S (Spring 2017)
Biostatistics/ResearchCPH 576B (Spring 2017)
Biostatistics/ResearchEPID 576B (Spring 2017)
Intro Statistical Analysis SASCPH 504 (Spring 2017)
Intro to Statistical AnalysisCPH 503 (Spring 2017)
Intro to Statistical AnalysisEPID 503 (Spring 2017)
Master's ReportCPH 909 (Spring 2017)
Biostatistics SeminarCPH 696S (Fall 2016)
Biostatistics/Pub HealthCPH 576A (Fall 2016)
Biostatistics/Pub HealthEPID 576A (Fall 2016)
Intro Statistical Analysis SASCPH 504 (Fall 2016)
Intro Statistical Analysis SASEPID 504 (Fall 2016)
Intro to Statistical AnalysisCPH 503 (Fall 2016)
Intro to Statistical AnalysisEPID 503 (Fall 2016)
Master's ReportCPH 909 (Fall 2016)
Master's ReportCPH 909 (Summer I 2016)
- Pearson, T., Caporaso, J. G., Yellowhair, M., Bokulich, N. A., Padi, M., Roe, D. J., Wertheim, B. C., Linhart, M., Martinez, J. A., Bilagody, C., Hornstra, H., Alberts, D. S., Lance, P., & Thompson, P. A. (2019). Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development. Cancer medicine.More infoIt has been previously reported that ursodeoxycholic acid (UDCA), a therapeutic bile acid, reduced risk for advanced colorectal adenoma in men but not women. Interactions between the gut microbiome and fecal bile acid composition as a factor in colorectal cancer neoplasia have been postulated but evidence is limited to small cohorts and animal studies. Using banked stool samples collected as part of a phase III randomized clinical trial of UDCA for the prevention of colorectal adenomatous polyps, we compared change in the microbiome composition after a 3-year intervention in a subset of participants randomized to oral UDCA at 8-10 mg/kg of body weight per day (n = 198) or placebo (n = 203). Study participants randomized to UDCA experienced compositional changes in their microbiome that were statistically more similar to other individuals in the UDCA arm than to those in the placebo arm. This reflected a UDCA-associated shift in microbial community composition (P 0.05). These UDCA-associated shifts in microbial community distance metrics from baseline to end-of-study were not associated with risk of any or advanced adenoma (all P > 0.05) in men or women. Separate analyses of microbial networks revealed an overrepresentation of Faecalibacterium prausnitzii in the post-UDCA arm and an inverse relationship between F prausnitzii and Ruminococcus gnavus. In men who received UDCA, the overrepresentation of F prausnitzii and underrepresentation of R gnavus were more prominent in those with no adenoma recurrence at follow-up compared to men with recurrence. This relationship was not observed in women. Daily UDCA use modestly influences the relative abundance of microbial species in stool and affects the microbial network composition with suggestive evidence for sex-specific effects of UDCA on stool microbial community composition as a modifier of colorectal adenoma risk.
- Augustus, G. J., Roe, D. J., Jacobs, E. T., Lance, P., & Ellis, N. A. (2018). Is increased colorectal screening effective in preventing distant disease?. PloS one, 13(7), e0200462.More infoScreening in the average risk population for colorectal cancer (CRC) is expected to reduce the incidence of distant (i.e., metastatic) CRCs at least as much as less advanced CRCs. Indeed, since 2000, during which time colonoscopy became widely used as a screening tool, the overall incidence of CRC has been reduced by 29%.
- Bauman, A., Ernst, K., Hayden, M., Roe, D. J., Murray, R., Agawo, M., Munga, S., Schmahl, E., & Taren, D. (2018). Assessing Community Health: An Innovative Tool for Measuring Height and Length. JOURNAL OF TROPICAL PEDIATRICS, 64(2), 146-150.
- Bea, J. W., Funk, J., Hetherington-Rauth, M., Wertheim, B. C., Mosquiera, L., Thuraisingam, R., Lee, V., Blew, R., Lohman, T., Roe, D. J., & Going, S. (2018). Anthropometry Versus Imaging for Prediction of Inflammation Among Hispanic Girls. Obesity (Silver Spring, Md.), 26(10), 1594-1602.More infoThis study aimed to compare total and regional estimates of body composition, by direct and indirect techniques, for the optimal prediction of C-reactive protein (CRP) among young (aged 9-12 years) Hispanic girls (N = 232).
- Blohm-Mangone, K., Burkett, N. B., Tahsin, S., Myrdal, P. B., Aodah, A., Ho, B., Janda, J., McComas, M., Saboda, K., Roe, D. J., Dong, Z., Bode, A. M., Petricoin, E. F., Calvert, V. S., Curiel-Lewandrowski, C., Alberts, D. S., Wondrak, G. T., & Dickinson, S. E. (2018). Pharmacological TLR4 antagonism using topical resatorvid blocks solar UV-induced skin tumorigenesis in SKH-1 mice. Cancer prevention research (Philadelphia, Pa.).More infoAn urgent need exists for the development of more efficacious molecular strategies targeting non-melanoma skin cancer (NMSC), the most common malignancy worldwide. Inflammatory signaling downstream of Toll-like receptor 4 (TLR4) has been implicated in several forms of tumorigenesis, yet its role in solar UV-induced skin carcinogenesis remains undefined. We have previously shown in keratinocyte cell culture and SKH-1 mouse epidermis that topical application of the specific TLR4 antagonist resatorvid (TAK-242) blocks acute UV-induced AP-1 and NF-κB signaling, associated with downregulation of inflammatory mediators and MAP Kinase phosphorylation. We therefore explored TLR4 as a novel target for chemoprevention of UV-induced NMSC. We selected the clinical TLR4 antagonist resatorvid based upon target specificity, potency, and physico-chemical properties. Here we confirm using ex-vivo permeability assays that topical resatorvid can be effectively delivered to skin, and using in vivo studies that topical resatorvid can block UV-induced AP-1 activation in mouse epidermis. We also report that in a UV-induced skin tumorigenesis model, topical resatorvid displays potent photochemopreventive activity, significantly suppressing tumor area and multiplicity. Tumors harvested from resatorvid-treated mice display reduced activity of UV-associated signaling pathways and a corresponding increase in apoptosis compared to tumors from control animals. Further mechanistic insight on resatorvid-based photochemoprevention was obtained from unsupervised hierarchical clustering analysis of protein readouts via reverse-phase protein microarray revealing a significant attenuation of key UV-induced proteomic changes by resatorvid in chronically treated high-risk SKH-1 skin prior to tumorigenesis. Taken together, our data identify TLR4 as a novel molecular target for topical photochemoprevention of NMSC.
- Bui, D. P., Oren, E., Roe, D. J., Brown, H. E., Harris, R. B., Knight, G. M., Gilman, R. H., & Grandjean, L. (2018). A Case Control Study to Identify Community Venues Associated with Genetically Clustered Multidrug-Resistant Tuberculosis Disease in Lima, Peru. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.More infoThe majority of tuberculosis transmission occurs in community settings. The primary aim of this study was to assess the association between exposure to community venues and multidrug-resistant tuberculosis (MDR-TB) disease. The secondary aim was to describe the social networks of MDR-TB cases and controls.
- Ding, J., Stopeck, A. T., Gao, Y., Marron, M. T., Wertheim, B. C., Altbach, M. I., Galons, J. P., Roe, D. J., Wang, F., Maskarinec, G., Thomson, C. A., Thompson, P. A., & Huang, C. (2018). Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI. Journal of magnetic resonance imaging : JMRI, 48(4), 971-981.More infoIncreased breast density is a significant independent risk factor for breast cancer, and recent studies show that this risk is modifiable. Hence, breast density measures sensitive to small changes are desired.
- Gilligan, A. M., Alberts, D. S., Roe, D. J., & Skrepnek, G. H. (2018). Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. The American journal of medicine, 131(10), 1187-1199.e5.More infoThe purpose of this study was to evaluate the impact of cancer upon a patient's net worth and debt in the US.
- Hetherington-Rauth, M., Bea, J. W., Blew, R. M., Funk, J. L., Hingle, M. D., Lee, V. R., Roe, D. J., Wheeler, M. D., Lohman, T. G., & Going, S. B. (2018). Relative contributions of lean and fat mass to bone strength in young Hispanic and non-Hispanic girls. Bone, 113, 144-150.More infoWith the high prevalence of childhood obesity, especially among Hispanic children, understanding how body weight and its components of lean and fat mass affect bone development is important, given that the amount of bone mineral accrued during childhood can determine osteoporosis risk later in life. The aim of this study was to assess the independent contributions of lean and fat mass on volumetric bone mineral density (vBMD), geometry, and strength in both weight-bearing and non-weight-bearing bones of Hispanic and non-Hispanic girls.
- Hetherington-Rauth, M., Bea, J. W., Blew, R. M., Funk, J. L., Lee, V. R., Roe, D. J., Sardinha, L. B., & Going, S. B. (2018). Relationship of cardiometabolic risk biomarkers with DXA and pQCT bone health outcomes in young girls. Bone, 120, 452-458.More infoExcess weight exerts the positive effect of mechanical loading on bone during development whereas obesity-related metabolic dysfunction may have a detrimental impact. In adults, the presence of metabolic syndrome and type 2 diabetes has been associated with compromised bone density, quality, and strength, and an increased incidence of fractures. The few studies that have investigated the role of cardio-metabolic disease risk biomarkers (CMR) on bone strength in children have given conflicting results. The aim of this study was to assess the combined and independent relationships of cardio-metabolic biomarkers with total body and regional bone parameters in young girls.
- Hetherington-Rauth, M., Bea, J. W., Blew, R. M., Funk, J. L., Lee, V. R., Varadi, T. C., Roe, D. J., Wheeler, M. D., & Going, S. B. (2018). Effect of cardiometabolic risk factors on the relationship between adiposity and bone mass in girls. International journal of obesity (2005), 42(6), 1185-1194.More infoChildhood obesity has been separately associated with cardiometabolic risk factors (CMRs) and increased risk of fracture. However, both augmented and compromised bone mass have been reported among overweight/obese children. Metabolic dysfunction, often co-existing with obesity, may explain the discrepancy in previous studies. The aim of this study was to examine whether the relationship between adiposity and dual-energy X-ray absorptiometry (DXA) derived bone mass differed in young girls with and without CMR(s).
- Huang, S., Hu, C., Bell, M. L., Billheimer, D., Guerra, S., Roe, D., Vasquez, M. M., & Bedrick, E. J. (2018). Regularized continuous-time Markov Model via elastic net. Biometrics, 74(3), 1045-1054.More infoContinuous-time Markov models are commonly used to analyze longitudinal transitions between multiple disease states in panel data, where participants' disease states are only observed at multiple time points, and the exact state paths between observations are unknown. However, when covariate effects are incorporated and allowed to vary for different transitions, the number of potential parameters to estimate can become large even when the number of covariates is moderate, and traditional maximum likelihood estimation and subset model selection procedures can easily become unstable due to overfitting. We propose a novel regularized continuous-time Markov model with the elastic net penalty, which is capable of simultaneous variable selection and estimation for large number of parameters. We derive an efficient coordinate descent algorithm to solve the penalized optimization problem, which is fully automatic and data driven. We further consider an extension where one of the states is death, and time of death is exactly known but the state path leading to death is unknown. The proposed method is extensively evaluated in a simulation study, and demonstrated in an application to real-world data on airflow limitation state transitions.
- Kohler, L. N., Harris, R. B., Oren, E., Roe, D. J., Lance, P., & Jacobs, E. T. (2018). Adherence to Nutrition and Physical Activity Cancer Prevention Guidelines and Development of Colorectal Adenoma. Nutrients, 10(8).More infoAdherence to the American Cancer Society's (ACS) Nutrition and Physical Activity Cancer Prevention Guidelines is associated with reductions in overall cancer incidence and mortality, including site-specific cancers such as colorectal cancer. We examined the relationship between baseline adherence to the ACS guidelines and (1) baseline adenoma characteristics and (2) odds of recurrent colorectal adenomas over 3 years of follow-up. Cross-sectional and prospective analyses with a pooled sample of participants from the Wheat Bran Fiber ( = 503) and Ursodeoxycholic Acid ( = 854) trials were performed. A cumulative adherence score was constructed using baseline self-reported data regarding body size, diet, physical activity and alcohol consumption. Multivariable logistic regression demonstrated significantly reduced odds of having three or more adenomas at baseline for moderately adherent (odds ratio [OR] = 0.67, 95% confidence intervals [CI]: 0.46⁻0.99) and highly adherent (OR = 0.50, 95% CI: 0.31⁻0.81) participants compared to low adherers (-trend = 0.005). Conversely, guideline adherence was not associated with development of recurrent colorectal adenoma (moderate adherence OR = 1.16, 95% CI: 0.85⁻1.59, high adherence OR = 1.23, 95% CI: 0.85⁻1.79).
- Mandair, D., Ho, Q., Wertheim, B., Johnson, G., Roe, D., Watchman, C., & Yi, S. K. (2018). Comparison of two thermoplastic immobilization mask systems in daily volumetric image guided radiation therapy for head and neck cancers. Biomedical Physics & Engineering Express, 4(055007).
- Martinez, J. A., Yang, J., Wertheim, B. C., Roe, D. J., Schriewer, A., Lance, P., Alberts, D. S., Hammock, B. D., & Thompson, P. A. (2018). Celecoxib use and circulating oxylipins in a colon polyp prevention trial. PloS one, 13(4), e0196398.More infoDrugs that inhibit cyclooxygenase (COX)-2 and the metabolism of arachidonic acid (ARA) to prostaglandin E2 are potent anti-inflammatory agents used widely in the treatment of joint and muscle pain. Despite their benefits, daily use of these drugs has been associated with hypertension, cardiovascular and gastrointestinal toxicities. It is now recognized that ARA is metabolized to a number of bioactive oxygenated lipids (oxylipins) by cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP450) enzymes. Currently, the contribution of individual variability in ARA metabolism in response to the COX-2 inhibitors and potential adverse effects remains poorly understood. Using patient samples from the randomized, placebo-controlled phase III selenium/celecoxib (Sel/Cel) trial for the prevention of colorectal adenomatous polyps, we analyzed plasma concentrations of 74 oxylipins in a subset of participants who received celecoxib (n = 90) or placebo (n = 95). We assessed the effect of celecoxib (with and without low dose aspirin) on circulating oxylipins and systolic blood pressure (SBP). Individual CYP450- and LOX- but not COX-derived metabolites were higher with celecoxib than placebo (P
- Padilla-Rodriguez, M., Parker, S. S., Adams, D. G., Westerling, T., Puleo, J. I., Watson, A. W., Hill, S. M., Noon, M., Gaudin, R., Aaron, J., Tong, D., Roe, D. J., Knudsen, B., & Mouneimne, G. (2018). The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion. Nature communications, 9(1), 2980.More infoEstrogen promotes growth of estrogen receptor-positive (ER+) breast tumors. However, epidemiological studies examining the prognostic characteristics of breast cancer in postmenopausal women receiving hormone replacement therapy reveal a significant decrease in tumor dissemination, suggesting that estrogen has potential protective effects against cancer cell invasion. Here, we show that estrogen suppresses invasion of ER+ breast cancer cells by increasing transcription of the Ena/VASP protein, EVL, which promotes the generation of suppressive cortical actin bundles that inhibit motility dynamics, and is crucial for the ER-mediated suppression of invasion in vitro and in vivo. Interestingly, despite its benefits in suppressing tumor growth, anti-estrogenic endocrine therapy decreases EVL expression and increases local invasion in patients. Our results highlight the dichotomous effects of estrogen on tumor progression and suggest that, in contrast to its established role in promoting growth of ER+ tumors, estrogen has a significant role in suppressing invasion through actin cytoskeletal remodeling.
- Łaniewski, P., Barnes, D., Goulder, A., Cui, H., Roe, D. J., Chase, D. M., & Herbst-Kralovetz, M. M. (2018). Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Scientific reports, 8(1), 7593.More infoWhile high-risk human papillomavirus (HPV) infection is a well-established risk factor for cervical cancer, there are likely other factors within the local microenvironment that contribute to cervical carcinogenesis. Here we investigated relationships between HPV, vaginal pH, vaginal microbiota (VMB) composition, level of genital immune mediators and severity of cervical neoplasm. We enrolled women with low- and high-grade cervical dysplasia (LGD, HGD), invasive cervical carcinoma (ICC), and healthy controls. HPV16, HPV45, HPV58, and HPV31 were the most prevalent in our cohort with HPV16 and HPV31 genotypes more prevalent in Hispanics. Vaginal pH was associated with ethnicity and severity of cervical neoplasm. Lactobacillus dominance decreased with the severity of cervical neoplasm, which correlated with elevated vaginal pH. Hispanic ethnicity was also associated with decreased Lactobacillus dominance. Furthermore, Sneathia was enriched in all precancerous groups, ICC, abnormal pH and Hispanic origin. Patients with ICC, but not LGD and HGD, exhibited increased genital inflammatory scores and elevated specific immune mediators. Notably, IL-36γ was significantly associated with ICC. Our study revealed local, host immune and microbial signatures associated with cervical carcinogenesis and provides an initial step to understanding the complex interplay between mucosal inflammation, HPV persistence and the VMB.
- Bauman, A., Ernst, K., Hayden, M., Roe, D. J., Murray, R., Agawo, M., Munga, S., Schmahl, E., & Taren, D. (2017). Assessing Community Health: An Innovative Tool for Measuring Height and Length. Journal of tropical pediatrics.More infoAnthropometric measurements, including height and length, are routinely needed for health research worldwide. Measurement boards are the current gold standard for obtaining the height and length of children. In community-based research, however, the size and weight of the measurement boards make them difficult and cumbersome to carry in the field. In addition, children and infants may express an unwillingness to be placed onto the measurement board. Electronic measuring tools commonly used in industry and contracting work are precise and portable. This study piloted a protocol to use an adapted laser measurement tool, the anthropometric measurement assist (AMA), to obtain height and recumbent length in children in Western Kenya. Intra- and inter-observer variability were determined and compared with measurement board measurements. Results of this initial pilot indicated that the AMA may be a viable alternative to measurement boards. The AMA can measure height/length accurately and reliably, is portable and is equivalent in price to measuring boards, making it a viable option for fieldwork in low-resourced countries.
- Gordon, J. S., Armin, J., D Hingle, M., Giacobbi, P., Cunningham, J. K., Johnson, T., Abbate, K., Howe, C. L., & Roe, D. J. (2017). Development and evaluation of the See Me Smoke-Free multi-behavioral mHealth app for women smokers. Translational behavioral medicine, 7(2), 172-184.More infoWomen face particular challenges when quitting smoking, especially those with weight concerns. A multi-behavioral smoking cessation intervention addressing these concerns and incorporating guided imagery may assist women to engage in healthy lifestyle behaviors. An mHealth app can easily disseminate such an intervention. The goals of this pilot study were to develop and test the feasibility and potential of the See Me Smoke-FreemHealth app to address smoking, diet, and physical activity among women smokers. We used pragmatic, direct-to-consumer methods to develop and test program content, functionality, and the user interface and conduct a pre-/post-test, 90-day pilot study. We enrolled 151 participants. Attrition was 52%, leaving 73 participants. At 90 days, 47% of participants reported 7-day abstinence and significant increases in physical activity and fruit consumption. Recruitment methods worked well, but similar to other mHealth studies, we experienced high attrition. This study suggests that a guided imagery mHealth app has the potential to address multiple behaviors. Future research should consider different methods to improve retention and assess efficacy.
- Gordon, J. S., Cunningham, J. K., Johnson, T., Armin, J. S., Hingle, M. D., Roe, D., Howe, C. L., & Giacobbi, P. (2017). Development and Evaluation of the See Me Smoke-Free Multi-Behavioral mHealth App for Women Smokers. Translational Behavioral Medicine.
- Hassounah, N. B., Nunez, M., Fordyce, C., Roe, D., Nagle, R., Bunch, T., & McDermott, K. M. (2017). Inhibition of Ciliogenesis Promotes Hedgehog Signaling, Tumorigenesis, and Metastasis in Breast Cancer. Molecular cancer research : MCR, 15(10), 1421-1430.More infoPrimary cilia are chemosensors that play a dual role to either activate or repress Hedgehog signaling, depending on presence or absence of ligand, respectively. While inhibition of ciliogenesis has been shown to be characteristic of breast cancers, the functional consequence is unknown. Here, for the first time, inhibition of ciliogenesis led to earlier tumor formation, faster tumor growth rate, higher grade tumor formation, and increased metastasis in the polyoma middle T (PyMT) mouse model of breast cancer. Inmodel systems, inhibition of ciliogenesis resulted in increased expression of Hedgehog-target genes through a mechanism involving loss of the repressor form of the GLI transcription factor (GLIR) and activation of Hedgehog target gene expression through cross-talk with TGF-alpha (TGFA) signaling. Bioinformatics analysis revealed that increased Hedgehog signaling is frequently associated with increased TGFA; signaling in patients with triple-negative breast cancers (TNBC), a particularly aggressive breast cancer subtype. These results identify a previously unrecognized role for inhibition of ciliogenesis in breast cancer progression. This study identifies inhibition of ciliogenesis as an important event for activation of Hedgehog signaling and progression of breast cancer to a more aggressive, metastatic disease.These findings change the way we understand how cancer cells turn on a critical signaling pathways and a provide rationale for developing novel therapeutic approaches to target noncanonical Hedgehog signaling for the treatment of breast cancer..
- Kim, W. S., Shin, C. N., Kathryn Larkey, L., & Roe, D. J. (2017). Development and Validation of the Narrative Quality Assessment Tool. Journal of nursing measurement, 25(1), 171-183.More infoThe use of storytelling in health promotion has grown over the past 2 decades, showing promise for moving people to initiate healthy behavior change. Given the increasingly prevalent role of storytelling in health promotion research and the need to more clearly identify what storytelling elements and mediators may better predict behavior change, there is a need to develop measures to specifically assess these factors in a cultural community context. The purpose of this study is to develop and preliminarily validate a narrative quality assessment tool for measuring elements of storytelling that are predicted to affect attitude and behavior change (i.e., narrative characteristics, identification, and transportation) within a cultural community setting using a culture-centric model.
- Kohler, L. N., Hibler, E. A., Harris, R. B., Oren, E., Roe, D. J., Jurutka, P. W., & Jacobs, E. T. (2017). Greater Adherence to Cancer Prevention Guidelines Is Associated with Higher Circulating Concentrations of Vitamin D Metabolites in a Cross-Sectional Analysis of Pooled Participants from 2 Chemoprevention Trials. The Journal of nutrition.More infoSeveral lifestyle factors targeted by the American Cancer Society (ACS) Nutrition and Physical Activity Cancer Prevention Guidelines are also associated with circulating concentrations of vitamin D metabolites. This suggests that greater adherence to the ACS guidelines may be related to better vitamin D status.
- Lance, P., Alberts, D. S., Thompson, P. A., Fales, L., Wang, F., San Jose, J., Jacobs, E. T., Goodman, P. J., Darke, A. K., Yee, M., Minasian, L., Thompson, I. M., & Roe, D. J. (2017). Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer prevention research (Philadelphia, Pa.), 10(1), 45-54.More infoSelenium and vitamin E micronutrients have been advocated for the prevention of colorectal cancer. Colorectal adenoma occurrence was used as a surrogate for colorectal cancer in an ancillary study to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) for prostate cancer prevention. The primary objective was to measure the effect of selenium (as selenomethionine) on colorectal adenomas occurrence, with the effect of vitamin E (as α-tocopherol) supplementation on colorectal adenoma occurrence considered as a secondary objective. Participants who underwent lower endoscopy while in SELECT were identified from a subgroup of the 35,533 men randomized in the trial. Adenoma occurrence was ascertained from the endoscopy and pathology reports for these procedures. Relative Risk (RR) estimates and 95% confidence intervals (CI) of adenoma occurrence were generated comparing those randomized to selenium versus placebo and to vitamin E versus placebo based on the full factorial design. Evaluable endoscopy information was obtained for 6,546 participants, of whom 2,286 had 1+ adenomas. Apart from 21 flexible sigmoidoscopies, all the procedures yielding adenomas were colonoscopies. Adenomas occurred in 34.2% and 35.7%, respectively, of participants whose intervention included or did not include selenium. Compared with placebo, the RR for adenoma occurrence in participants randomized to selenium was 0.96 (95% CI, 0.90-1.02; P = 0.194). Vitamin E did not affect adenoma occurrence compared with placebo (RR = 1.03; 95% CI, 0.96-1.10; P = 0.38). Neither selenium nor vitamin E supplementation can be recommended for colorectal adenoma prevention. Cancer Prev Res; 10(1); 45-54. ©2016 AACR.
- Langston, M., Dennis, L., Lynch, C., Roe, D., & Brown, H. (2017). Temporal Trends in Satellite-Derived Erythemal UVB and Implications for Ambient Sun Exposure Assessment. International journal of environmental research and public health, 14(2).More infoUltraviolet radiation (UVR) has been associated with various health outcomes, including skin cancers, vitamin D insufficiency, and multiple sclerosis. Measurement of UVR has been difficult, traditionally relying on subject recall. We investigated trends in satellite-derived UVB from 1978 to 2014 within the continental United States (US) to inform UVR exposure assessment and determine the potential magnitude of misclassification bias created by ignoring these trends. Monthly UVB data remotely sensed from various NASA satellites were used to investigate changes over time in the United States using linear regression with a harmonic function. Linear regression models for local geographic areas were used to make inferences across the entire study area using a global field significance test. Temporal trends were investigated across all years and separately for each satellite type due to documented differences in UVB estimation. UVB increased from 1978 to 2014 in 48% of local tests. The largest UVB increase was found in Western Nevada (0.145 kJ/m2 per five-year increment), a total 30-year increase of 0.87 kJ/m2. This largest change only represented 17% of total ambient exposure for an average January and 2% of an average July in Western Nevada. The observed trends represent cumulative UVB changes of less than a month, which are not relevant when attempting to estimate human exposure. The observation of small trends should be interpreted with caution due to measurement of satellite parameter inputs (ozone and climatological factors) that may impact derived satellite UVR nearly 20% compared to ground level sources. If the observed trends hold, satellite-derived UVB data may reasonably estimate ambient UVB exposures even for outcomes with long latency phases that predate the satellite record.
- Thomson, C. A., Chow, H. H., Wertheim, B. C., Roe, D. J., Stopeck, A., Maskarinec, G., Altbach, M., Chalasani, P., Huang, C., Strom, M. B., Galons, J. P., & Thompson, P. A. (2017). A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast cancer research and treatment, 165(1), 97-107.More infoDiindolylmethane (DIM), a bioactive metabolite of indole-3-carbinol found in cruciferous vegetables, has proposed cancer chemoprevention activity in the breast. There is limited evidence of clinically relevant activity of DIM or long-term safety data of its regular use. A randomized, double-blind, placebo-controlled trial was conducted to determine the activity and safety of combined use of BioResponse DIM® (BR-DIM) with tamoxifen.
- Vasquez, M. M., Hu, C., Roe, D. J., Halonen, M., & Guerra, S. (2017). Measurement error correction in the least absolute shrinkage and selection operator model when validation data are available. Statistical methods in medical research, 962280217734241.More infoMeasurement of serum biomarkers by multiplex assays may be more variable as compared to single biomarker assays. Measurement error in these data may bias parameter estimates in regression analysis, which could mask true associations of serum biomarkers with an outcome. The Least Absolute Shrinkage and Selection Operator (LASSO) can be used for variable selection in these high-dimensional data. Furthermore, when the distribution of measurement error is assumed to be known or estimated with replication data, a simple measurement error correction method can be applied to the LASSO method. However, in practice the distribution of the measurement error is unknown and is expensive to estimate through replication both in monetary cost and need for greater amount of sample which is often limited in quantity. We adapt an existing bias correction approach by estimating the measurement error using validation data in which a subset of serum biomarkers are re-measured on a random subset of the study sample. We evaluate this method using simulated data and data from the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD). We show that the bias in parameter estimation is reduced and variable selection is improved.
- Chen, Y., Gao, M., Duncan, J. K., Ran, D., Roe, D. J., Belin, M. W., & Wang, M. (2016). Excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay for recalcitrant filamentary fungal keratitis: A retrospective comparative clinical data analysis. Experimental and therapeutic medicine, 12(5), 3014-3020.More infoThe aim of the present study was to investigate the efficacy of a novel surgical intervention, excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay (EKCAI), for the treatment of recalcitrant filamentary fungal keratitis. A retrospective analysis was performed of patients who underwent excisional keratectomy combined with conjunctival flap inlay (EKCFI), EKCAI or therapeutic penetrating keratoplasty (TPK) from January 2006 to January 2011. Recalcitrance was determined as being unresponsive to standard medical antifungal therapy for at ≥1 week. Outcome measures among the three intervention modalities were compared. A total of 128 patients had a follow-up of ≥1 year after the primary intervention. The success rates of interventions at 1-year follow-up were 58.33% in the EKCFI group, 88.37% in the EKCAI group and 93.44% in the TPK group (P
- Hincapie, A., MacKinnon, N., Malone, D. C., Slack, M. K., Roe, D., & Warholak, T. L. (2016). Relationship between Patients’ Perceptions of Care Quality and Patient Safety in 11 Countries: A Secondary Data Analysis. Quality and Management in Health Care, 25(1), 13-21.
- Jacobs, E. T., Haussler, M. R., Alberts, D. S., Kohler, L. N., Lance, P., Martínez, M. E., Roe, D. J., & Jurutka, P. W. (2016). Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer prevention research (Philadelphia, Pa.), 9(7), 589-97.More infoAlthough hydrophobic bile acids have been demonstrated to exhibit cytotoxic and carcinogenic effects in the colorectum, ursodeoxycholic acid (UDCA) has been investigated as a potential chemopreventive agent. Vitamin D has been shown to play a role in both bile acid metabolism and in the development of colorectal neoplasia. Using a cross-sectional design, we sought to determine whether baseline circulating concentrations of the vitamin D metabolites 25(OH)D and 1,25(OH)2D were associated with baseline fecal bile acid concentrations in a trial of UDCA for the prevention of colorectal adenoma recurrence. We also prospectively evaluated whether vitamin D metabolite concentrations modified the effect of UDCA on adenoma recurrence. After adjustment for age, sex, BMI, physical activity, and calcium intake, adequate concentrations of 25(OH)D (≥30 ng/mL) were statistically significantly associated with reduced odds for high levels of total [OR, 0.61; 95% confidence interval (CI), 0.38-0.97], and primary (OR, 0.61; 95% CI, 0.38-0.96) bile acids, as well as individually with chenodeoxycholic acid (OR, 0.39; 95% CI, 0.24-0.63) and cholic acid (OR, 0.56; 95% CI, 0.36-0.90). No significant associations were observed for 1,25(OH)2D and high versus low fecal bile acid concentrations. In addition, neither 25(OH)D nor 1,25(OH)2D modified the effect of UDCA on colorectal adenoma recurrence. In conclusion, this is the first study to demonstrate an inverse relationship between circulating levels of 25(OH)D and primary fecal bile acid concentrations. These results support prior data demonstrating that vitamin D plays a key role in bile acid metabolism, and suggest a potential mechanism of action for 25(OH)D in colorectal cancer prevention. Cancer Prev Res; 9(7); 589-97. ©2016 AACR.
- Kohler, L. N., Garcia, D. O., Harris, R. B., Oren, E., Roe, D. J., & Jacobs, E. T. (2016). Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 25(7), 1018-28.More infoMany studies have reported that adherence to health promotion guidelines for diet, physical activity, and maintenance of healthy body weight may decrease cancer incidence and mortality. A systematic review was performed to examine associations between adherence to established cancer prevention guidelines for diet and physical activity and overall cancer incidence and mortality. PubMed, Google Scholar, and Cochrane Reviews databases were searched following the current recommendations of Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Twelve studies met inclusion criteria for this review. High versus low adherence to established nutrition and physical activity cancer prevention guidelines was consistently and significantly associated with decreases of 10% to 61% in overall cancer incidence and mortality. Consistent significant reductions were also shown for breast cancer incidence (19%-60%), endometrial cancer incidence (23%-60%), and colorectal cancer incidence in both men and women (27%-52%). Findings for lung cancer incidence were equivocal, and no significant relationships were found between adherence and ovarian or prostate cancers. Adhering to cancer prevention guidelines for diet and physical activity is consistently associated with lower risks of overall cancer incidence and mortality, including for some site-specific cancers. Cancer Epidemiol Biomarkers Prev; 25(7); 1018-28. ©2016 AACR.
- Kohler, L. N., Jacobs, E. T., Roe, D., Garcia, D. O., Oren, E., Harris, R. B., Harris, R. B., Oren, E., Garcia, D. O., Roe, D., Kohler, L. N., & Jacobs, E. T. (2016). Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review.. Cancer Epidemiology, Biomarkers & Prevention.
- Kohler, L. N., Jacobs, E. T., Roe, D., Garcia, D. O., Oren, E., Harris, R. B., Harris, R. B., Oren, E., Roe, D., Garcia, D. O., Kohler, L. N., & Jacobs, E. T. (2016). Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review.. Cancer Epidemiology, Biomarkers & Prevention.
- Larkey, L. K., Roe, D. J., Smith, L., & Millstine, D. (2016). Exploratory outcome assessment of Qigong/Tai Chi Easy on breast cancer survivors. Complementary therapies in medicine, 29, 196-203.More infoBreast cancer survivors (BCSs) experience symptoms affecting overall quality of life (QOL), often for a prolonged period post-treatment. Meditative Movement (MM), including Qigong and Tai Chi Easy (QG/TCE), has demonstrated benefit for improving QOL issues such as fatigue and sleep, but there is limited evidence of its impact on cognitive function, overall physical activity, and body weight for BCSs.
- Patanwala, A. E., Erstad, B. L., Roe, D. J., & Sakles, J. C. (2016). Succinylcholine Is Associated with Increased Mortality When Used for Rapid Sequence Intubation of Severely Brain Injured Patients in the Emergency Department. Pharmacotherapy, 36(1), 57-63.More infoTo compare succinylcholine and rocuronium regarding mortality in patients with traumatic brain injury (TBI) who are intubated in the emergency department (ED).
- Poplin, G. S., Roe, D. J., Burgess, J. L., Peate, W. F., & Harris, R. B. (2016). Fire fit: assessing comprehensive fitness and injury risk in the fire service. International archives of occupational and environmental health, 89(2), 251-9.More infoThis study sought to develop a comprehensive measure of fitness that is predictive of injury risk and can be used in the fire service to assess individual-level health and fit-for-duty status.
- Tate, T. H., Baggett, B., Rice, P. F., Koevary, J. W., Orsinger, G. V., Nymeyer, A. C., Welge, W. A., Saboda, K., Roe, D. J., Hatch, K. D., Chambers, S. K., Utzinger, U., & Barton, J. K. (2016). Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection. Journal of biomedical optics, 21(5), 56005.
- Thompson, P. A., Ashbeck, E. L., Roe, D. J., Fales, L., Buckmeier, J., Wang, F., Bhattacharyya, A., Hsu, C. H., Chow, H. H., Ahnen, D. J., Boland, C. R., Heigh, R. I., Fay, D. E., Hamilton, S. R., Jacobs, E. T., Martinez, M. E., Alberts, D. S., & Lance, P. (2016). Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. Journal of the National Cancer Institute, 108(12).More infoSelenium supplementation may help to prevent colorectal cancer; as precursors of colorectal cancer, colorectal adenomas are a surrogate for colorectal cancer. Selenium supplementation may increase risk of type 2 diabetes (T2D).
- Thompson, P. A., Ashbeck, E. L., Roe, D. J., Fales, L., Buckmeier, J., Wang, F., Bhattacharyya, A., Hsu, C. H., Chow, S. H., Ahnen, D. J., Boland, C. R., Heigh, R. I., Fay, D. E., Hamilton, S. R., Jacobs, E. T., Martinez, E. M., Alberts, D. S., & Lance, P. (2016). Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. Journal of the National Cancer Institute, 108(12).More infoCyclooxygenase (COX)-2 inhibitors such as celecoxib were designed to preserve anti-inflammatory activity without inhibiting COX-1. Downregulation of COX-2 inhibits colorectal carcinogenesis.
- Vasquez, M. M., Hu, C., Roe, D. J., Chen, Z., Halonen, M., & Guerra, S. (2016). Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC medical research methodology, 16(1), 154.More infoThe study of circulating biomarkers and their association with disease outcomes has become progressively complex due to advances in the measurement of these biomarkers through multiplex technologies. The Least Absolute Shrinkage and Selection Operator (LASSO) is a data analysis method that may be utilized for biomarker selection in these high dimensional data. However, it is unclear which LASSO-type method is preferable when considering data scenarios that may be present in serum biomarker research, such as high correlation between biomarkers, weak associations with the outcome, and sparse number of true signals. The goal of this study was to compare the LASSO to five LASSO-type methods given these scenarios.
- Baker, A. F., Malm, S. W., Pandey, R., Laughren, C., Cui, H., Roe, D., & Chambers, S. K. (2015). Evaluation of a hypoxia regulated gene panel in ovarian cancer. Cancer Microenvironment, 8(1), 45-56.More infoA panel of nine hypoxia regulated genes, selected from a previously published fifty gene panel, was investigated for its ability to predict hypoxic ovarian cancer phenotypes. All nine genes including vascular endothelial growth factor A, glucose transporter 1, phosphoglycerate mutase 1, lactate dehydrogenase A, prolyl 4-hydroxylase, alpha-polypeptide 1, adrenomedullin, N-myc downstream regulated 1, aldolase A, and carbonic anhydrase 9 were upregulated in the HEY and OVCAR-3 human ovarian cell lines cultured in vitro under hypoxic compared to normoxic conditions as measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The gene panel was also elevated in HEY xenograft tumor tissue compared to HEY cells cultured in normoxia. The HEY xenograft tissue demonstrated heterogeneous positive immunohistochemical staining for the exogenous hypoxia biomarker pimonidazole, and the hypoxia regulated protein carbonic anhydrase IX. A quantitative nuclease protection assay (qNPA) was developed which included the nine hypoxia regulated genes. The qNPA assay provided similar results to those obtained using qRT-PCR for cultured cell lines. The qNPA assay was also evaluated using paraffin embedded fixed tissues including a set of five patient matched primary and metastatic serous cancers and four normal ovaries. In this small sample set the average gene expression was higher in primary and metastatic cancer tissue compared to normal ovaries for the majority of genes investigated. This study supports further evaluation by qNPA of this gene panel as an alternative or complimentary method to existing protein biomarkers to identify ovarian cancers with a hypoxic phenotype.
- Bea, J. W., Jurutka, P. W., Hibler, E. A., Lance, P., Martinez, M. E., Roe, D. J., Molmenti, C. L., Thompson, P. A., & Jacobs, E. T. (2015). Concentrations of the Vitamin D Metabolite 1,25(OH)(2)D and Odds of Metabolic Syndrome and its Components. Metabolism: Clinical and Experimental, 64(3), 447-459.
- Bea, J. W., Thomson, C. A., Wertheim, B. C., Nicholas, J. S., Ernst, K. C., Hu, C., Jackson, R. D., Cauley, J. A., Lewis, C. E., Caan, B., Roe, D. J., & Chen, Z. (2015). Risk of Mortality According to Body Mass Index and Body Composition Among Postmenopausal Women. American Journal of Epidemiology, 182(7), 585-596.
- Chalasani, P., Marron, M., Roe, D., Clarke, K., Iannone, M., Livingston, R. B., Shan, J. S., & Stopeck, A. T. (2015). A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer. Cancer Medicine, 4(7), 1051-9.More infoBavituximab is a chimeric monoclonal antibody that targets phosphatidylserine (PS). PS is externalized on cells in the tumor microenvironment when exposed to hypoxia and/or other physiological stressors. On attaching to PS, bavituximab is thought to promote antitumor immunity through its effects on PS receptors in monocytes, and myeloid-derived suppressor cells, as well as trigger antitumor effects by inducing an antibody-dependent cellular cytotoxicity on tumor-associated endothelial cells. We conducted a phase I clinical trial of bavituximab in combination with paclitaxel in patients with HER2-negative metastatic breast cancer. Patients were treated with weekly paclitaxel (80 mg/m(2) for 3/4 weeks) and weekly bavituximab (3 mg/kg for 4/4 weeks). Correlative studies included the measurement of circulating microparticles, endothelial cells, and apoptotic tumor cells by flow cytometry. Fourteen patients with metastatic breast cancer were enrolled; all were evaluable for toxicity and 13 were evaluable for response. Treatment resulted in an overall response rate (RR) of 85% with a median progression-free survival (PFS) of 7.3 months. Bone pain, fatigue, headache, and neutropenia were the most common adverse effects. Infusion-related reactions were the most common adverse event related to bavituximab therapy. Correlative studies showed an increase in the PS-expressing apoptotic circulating tumor cells in response to bavituximab, but not with paclitaxel. No changes in the number of circulating endothelial cells or apoptotic endothelial cells were observed with therapy. Platelet and monocyte-derived microparticles decreased after initiation of bavituximab. Bavituximab in combination with paclitaxel is well tolerated for treatment of patients with metastatic breast cancer with promising results observed in terms of clinical RRs and PFS. The toxicity profile of bavituximab is notable for manageable infusion-related reactions with no evidence for increased thrombogenicity. Recent preclinical data suggest that bavituximab can also promote antitumor immune activity that should be explored in future clinical trials.
- Hibler, E. A., Klimentidis, Y. C., Jurutka, P. W., Kohler, L. N., Lance, P., Roe, D. J., Thompson, P. A., & Jacobs, E. T. (2015). CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutrition and Cancer, 67(7), 1131-1141.
- Hingle, M. D., Turner, T., Kutob, R., Merchant, N., Roe, D. J., Stump, C., & Going, S. B. (2015). The EPIC Kids Study: a randomized family-focused YMCA-based intervention to prevent type 2 diabetes in at-risk youth. BMC Public Health, 15.
- Hingle, M. D., Turner, T., Kutob, R., Merchant, N., Roe, D. J., Stump, C., & Going, S. B. (2015). The EPIC Kids Study: a randomized family-focused YMCA-based intervention to prevent type 2 diabetes in at-risk youth. BMC public health, 15, 1253.More infoIt is well established that behavioral lifestyle interventions resulting in modest weight reduction in adults can prevent or delay type 2 diabetes mellitus; however in children, successful weight management interventions are rarely found outside of controlled clinical settings. The lack of effective community-based programs is a barrier to reducing obesity prevalence and diabetes risk in children. The objective of our study is to develop and test a group-randomized family-centered community-based type 2 diabetes prevention intervention targeting at-risk children, 9- to 12-years-old.
- Hongu, N., Pope, B. T., Bilgiç, P., Orr, B. J., Suzuki, A., Kim, A. S., Merchant, N. C., & Roe, D. J. (2015). Usability of a smartphone food picture app for assisting 24-hour dietary recall: a pilot study. Nutrition Research and Practice, 9(2), 207-12.More infoThe Recaller app was developed to help individuals record their food intakes. This pilot study evaluated the usability of this new food picture application (app), which operates on a smartphone with an embedded camera and Internet capability.
- Larkey, L. K., McClain, D., Roe, D. J., Hector, R. D., Lopez, A. M., Sillanpaa, B., & Gonzalez, J. (2015). Randomized Controlled Trial of Storytelling Compared to a Personal Risk Tool Intervention on Colorectal Cancer Screening in Low-Income Patients. American Journal of Health Promotion.More infoPurpose . Screening rates for colorectal cancer (CRC) lag for low-income, minority populations, contributing to poorer survival rates. A model of storytelling as culture-centric health promotion was tested for promoting CRC screening. Design . A two-group parallel randomized controlled trial. Setting . Primary care, safety-net clinics. Subjects . Low-income patients due for CRC screening, ages 50 to 75 years, speaking English or Spanish. Intervention . Patients were exposed to either a video created from personal stories composited into a drama about "Papa" receiving CRC screening, or an instrument estimating level of personal cancer risk. Patients received a health care provider referral for CRC screening and were followed up for 3 months to document adherence. Measures . Behavioral factors related to the narrative model (identification and engagement) and theory of planned behavior. Analysis . Main effects of the interventions on screening were tested, controlling for attrition factors, and demographic factor associations were assessed. Path analysis with model variables was used to test the direct effects and multiple mediator models. Results . Main effects on CRC screening (roughly half stool-based tests, half colonoscopy) did not indicate significant differences (37% and 42% screened for storytelling and risk-based messages, respectively; n = 539; 33.6% male; 62% Hispanic). Factors positively associated with CRC screening included being female, Hispanic, married or living with a partner, speaking Spanish, having a primary care provider, lower income, and no health insurance. Engagement, working through positive attitudes toward the behavior, predicted CRC screening. Conclusion . A storytelling and a personalized risk-tool intervention achieved similar levels of screening among unscreened/underscreened, low-income patients. Factors usually associated with lower rates of screening (e.g., no insurance, being Hispanic) were related to more adherence. Both interventions' engagement factor facilitated positive attitudes about CRC screening associated with behavior change.
- Larkey, L. K., Roe, D. J., Weihs, K. L., Jahnke, R., Lopez, A. M., Rogers, C. E., Oh, B., & Guillen-Rodriguez, J. (2015). Randomized Controlled Trial of Qigong/Tai Chi Easy on Cancer-Related Fatigue in Breast Cancer Survivors. Annals of Behavioral Medicine, 49(2), 165-176.
- LeGendre-McGhee, S., Rice, P. S., Wall, R. A., Sprute, K. J., Bommireddy, R., Luttman, A. M., Nagle, R. B., Abril, E. R., Farrell, K., Hsu, C., Roe, D. J., Gerner, E. W., Ignatenko, N. A., & Barton, J. K. (2015). Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography. Cancer Growth and Metastasis, 8(Suppl 1), 63-80.More infoOptical coherence tomography (OCT) is a high-resolution, nondestructive imaging modality that enables time-serial assessment of adenoma development in the mouse model of colorectal cancer. In this study, OCT was utilized to evaluate the effectiveness of interventions with the experimental antitumor agent α-difluoromethylornithine (DFMO) and a nonsteroidal anti-inflammatory drug sulindac during early [chemoprevention (CP)] and late stages [chemotherapy (CT)] of colon tumorigenesis. Biological endpoints for drug interventions included OCT-generated tumor number and tumor burden. Immunochistochemistry was used to evaluate biochemical endpoints [Ki-67, cleaved caspase-3, cyclooxygenase (COX)-2, β-catenin]. K-Ras codon 12 mutations were studied with polymerase chain reaction-based technique. We demonstrated that OCT imaging significantly correlated with histological analysis of both tumor number and tumor burden for all experimental groups (P < 0.0001), but allows more accurate and full characterization of tumor number and burden growth rate because of its time-serial, nondestructive nature. DFMO alone or in combination with sulindac suppressed both the tumor number and tumor burden growth rate in the CP setting because of DFMO-mediated decrease in cell proliferation (Ki-67, P < 0.001) and K-RAS mutations frequency (P = 0.04). In the CT setting, sulindac alone and DFMO/sulindac combination were effective in reducing tumor number, but not tumor burden growth rate. A decrease in COX-2 staining in DFMO/sulindac CT groups (COX-2, P < 0.01) confirmed the treatment effect. Use of nondestructive OCT enabled repeated, quantitative evaluation of tumor number and burden, allowing changes in these parameters to be measured during CP and as a result of CT. In conclusion, OCT is a robust minimally invasive method for monitoring colorectal cancer disease and effectiveness of therapies in mouse models.
- Stephen, R. M., Jha, A. K., Roe, D. J., Trouard, T. P., Galons, J., Kupinski, M. A., Frey, G., Cui, H., Squire, S., Pagel, M. D., Rodriguez, J. J., Gillies, R. J., & Stopeck, A. T. (2015). Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis. Magnetic Resonance Imaging, 33(10), 1267-1273.
- Whitlow, P. G., Saboda, K., Roe, D. J., Bazzell, S., & Wilson, C. (2015). Topical Analgesia Treats Pain and Decreases Propofol Use During Lumbar Punctures in a Randomized Pediatric Leukemia Trial. Pediatric Blood & Cancer, 62(1), 85-90.
- Barr, P. M., Miller, T. P., Friedberg, J. W., Peterson, D. R., Baran, A. M., Herr, M., Spier, C. M., Cui, H., Roe, D. J., Persky, D. O., Casulo, C., Littleton, J., Schwartz, M., Puvvada, S., Landowski, T. H., Rimsza, L. M., Dorr, R. T., Fisher, R. I., Bernstein, S. H., & Briehl, M. M. (2014). Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood, 124(8), 1259-65.More infoLymphoma cells are subject to higher levels of oxidative stress compared with their normal counterparts and may be vulnerable to manipulations of the cellular redox balance. We therefore designed a phase 2 study of imexon (Amplimexon/NSC-714597), a prooxidant molecule, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL). Imexon was administered at 1000 mg/m(2) IV daily for 5 days in 21-day cycles. Gene expression analysis performed on pretreatment tumor specimens included 13 transcripts used to generate a redox signature score, previously demonstrated to correlate with lymphoma prognosis. Twenty-two patients were enrolled having follicular (n = 9), diffuse large B-cell (DLBCL) (n = 5), mantle cell (n = 3), transformed follicular (n = 2), small lymphocytic (n = 2), and Burkitt (n = 1) lymphoma. The most common grade 3/4 adverse events were anemia (14%) and neutropenia (9%). The overall response rate was 30%, including responses in follicular lymphoma (4 of 9) and DLBCL (2 of 5). Gene expression analyses revealed CD68 and the redox-related genes, GPX1 and SOD2, as well as a higher redox score to correlate with clinical responses. Therefore, pretreatment markers of oxidative stress may identify patients likely to respond to this therapeutic approach. This trial was registered at www.clinicaltrials.gov as #NCT01314014.
- Hongu, N., Going, S. B., Orr, B. J., Hingle, M. D., Roe, D., Houtkooper, L. K., Merchant, N. C., & Yael, G. V. (2014). Mobile Technologies for Promoting Health and Physical Activity. American College of Sports Medicine, 18(4), 8-15.
- Hongu, N., Going, S. B., Orr, B. J., Merchant, N. C., Hingle, M. D., Roe, D., Greenblatt, Y. V., & Houtkooper, L. K. (2014). TACH SAVVY: Mobile Technologies for Promoting Health and Physical Activity.. ACSM's Health & Fitness Journal, 18(4), 8-15.
- Hongu, N., Pope, B. T., Bilgic, P., Orr, B. J., Suzuki, A., Kim, A. S., Merchant, N. C., & Roe, D. (2014). Usability of a smartphone food picture app for assisting 24-hour dietary recall: a pilot study.. Nutrition Research and Practice.
- Larkey, L. K., Roe, D. J., Weihs, K. L., Jahnke, R., Lopez, A. M., Rogers, C. E., Oh, B., & Guillen-Rodriguez, J. (2014). Randomized Controlled Trial of Qigong/Tai Chi Easy on Cancer-Related Fatigue in Breast Cancer Survivors. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.More infoMany breast cancer survivors experience fatigue, mood, and sleep disturbances.
- Molmenti, C. L., Hibler, E. A., Ashbeck, E. L., Thomson, C. A., Garcia, D. O., Roe, D., Harris, R. B., Lance, P., Cisneroz, M., Martinez, M. E., Thompson, P. A., & Jacobs, E. T. (2014). Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer causes & control : CCC, 25(10), 1387-95.More infoThe association between physical activity and colorectal adenoma is equivocal. This study was designed to assess the relationship between physical activity and colorectal adenoma recurrence.
- Poplin, G. S., Roe, D. J., Peate, W., Harris, R. B., & Burgess, J. L. (2014). The association of aerobic fitness with injuries in the fire service. American journal of epidemiology, 179(2).More infoThe aim of the present study was to understand the risk of injury in relation to fitness in a retrospective occupational cohort of firefighters in Tucson, Arizona, from 2005 to 2009. Annual medical evaluations and injury surveillance data were linked to compare levels of aerobic fitness in injured employees with those in noninjured employees. The individual outcomes evaluated included all injuries, exercise-related injuries, and sprains and strains. Time-to-event analyses were conducted to determine the association between levels of fitness and injury likelihood. Fitness, defined by relative aerobic capacity (Vo2max), was associated with injury risk. Persons in the lowest fitness level category (Vo2max 48 mL/kg/minute). Those with a Vo2max between 43 and 48 mL/kg/minute were 1.38 times (95% confidence interval: 1.06, 1.78) more likely to incur injury. Hazard ratios were found to be greater for sprains and strains. Our results suggest that improving relative aerobic capacity by 1 metabolic equivalent of task (approximately 3.5 mL/kg/minute) reduces the risk of any injury by 14%. These findings illustrate the importance of fitness in reducing the risk of injury in physically demanding occupations, such as the fire service, and support the need to provide dedicated resources for structured fitness programming and the promotion of injury prevention strategies to people in those fields.
- Smith, L. L., Larkey, L. K., Roe, D. J., Bucho-Gonzalez, J. A., Saboda, K., & Ainsworth, B. E. (2014). Self-reported physical activity patterns among low-income Latina women in Arizona. Women's health issues : official publication of the Jacobs Institute of Women's Health, 24(3), e353-61.More infoAdherence to recommendations for physical activity (PA) among adults in the United States is reported as poor, particularly among low-income Latinos. In particular, Latina women are at increased risk for inactivity and chronic illness, but national health survey reports aggregate data across demographic strata, limiting descriptive information that could guide targeted PA promotion. The purpose of the study was to determine PA patterns among a low-income group of Latina women in the southwestern United States.
- Smith, L. L., Larkey, L. K., Roe, D. R., Bunch-Gonzalez, J. A., Saboda, K., & Ainsworth, B. E. (2014). Self-reported physical activity patterns among low-income Latina women in Arizona. Womens Health Issues, 24(3), e353-361.
- Amanda F. Baker, ., Denise J. Roe, ., Cynthia Laughren, ., Janice L. Cohen, ., Heather M. Wright, ., Mary C. Clouser, ., Haiyan Cui, ., David S. Alberts, ., & Setsuko K. Chambers, . (2013). Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer. Investigational New Drugs, 31(1), 160-166.
- Angela N. Bartley, ., Nila Parikh, ., Chiu-Hsieh Hsu, ., Denise J. Roe, ., Julie A. Buckmeier, ., Lynda Corley, ., Ron A. Phipps, ., Gary Gallick, ., Peter Lance, ., Patricia A. Thompson, ., & Stanley R. Hamilton, . (2013). Colorectal adenoma stem-like cell populations: Associations with adenoma characteristics and metachronous colorectal neoplasia. Cancer Prevention Research, 6(11), 1162-1170.
- Bartley, A. N., Parikh, N., Hsu, C., Roe, D. J., Buckmeier, J. A., Corley, L., Phipps, R. A., Gallick, G., Lance, P., Thompson, P. A., & Hamilton, S. R. (2013). Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia. Cancer prevention research (Philadelphia, Pa.), 6(11).More infoCancer stem cells have tumor-initiation and tumor-maintenance capabilities. Stem-like cells are present in colorectal adenomas, but their relationship to adenoma pathology and patient characteristics, including metachronous development of an additional adenoma ("recurrence"), has not been studied extensively. We evaluated the expression of aldehyde dehydrogenase isoform 1A1 (ALDH1A1), a putative stem cell marker, in baseline adenomas from the placebo arm of chemoprevention trial participants with colonoscopic follow-up. An exploratory set of 20 baseline adenomas was analyzed by ALDH1A1 immunohistochemistry with morphometry, and a replication set of 89 adenomas from 76 high-risk participants was evaluated by computerized image analysis. ALDH1A1-labeling indices (ALI) were similar across patient characteristics and in advanced and nonadvanced adenomas. There was a trend toward higher ALIs in adenomas occurring in the right than left colon (P = 0.09). ALIs of synchronous adenomas were correlated (intraclass correlation coefficient 0.67). Participants in both sample sets who developed a metachronous adenoma had significantly higher ALIs in their baseline adenoma than participants who remained adenoma free. In the replication set, the adjusted odds for metachronous adenoma increased 1.46 for each 10% increase in ALIs (P = 0.03). A best-fit algorithm-based cutoff point of 22.4% had specificity of 75.0% and positive predictive value of 70.0% for metachronous adenoma development. A larger population of ALDH1A1-expressing cells in an adenoma is associated with a higher risk for metachronous adenoma, independent of adenoma size or histopathology. If confirmed, ALDH1A1 has potential as a novel biomarker in risk assessment and as a potential stem cell target for chemoprevention.
- Christine L. Sardo, ., Joseph P. Kitzmiller, ., Glen Apseloff, ., Robin B. Harris, ., Denise J. Roe, ., Gary D. Stoner, ., & Elizabeth T. Jacobs, . (2013). An open-label randomized crossover trial of lyophilized black raspberries on postprandial inflammation in older overweight males: A pilot study. American Journal of Therapeutics.
- Hongu, N., Orr, B. J., Roe, D. J., Reed, R. G., & Going, S. B. (2013). Global positioning system watches for estimating energy expenditure. Journal of strength and conditioning research / National Strength & Conditioning Association, 27(11).More infoGlobal positioning system (GPS) watches have been introduced commercially, converting frequent measurements of time, location, speed (pace), and elevation into energy expenditure (EE) estimates. The purpose of this study was to compare EE estimates of 4 different GPS watches (Forerunner, Suunto, Polar, Adeo), at various walking speeds, with EE estimate from a triaxial accelerometer (RT3), which was used as a reference measure in this study. Sixteen healthy young adults completed the study. Participants wore 4 different GPS watches and an RT3 accelerometer and walked at 6-minute intervals on an outdoor track at 3 speeds (3, 5, and 7 km/hr). The statistical significance of differences in EE between the 3 watches was assessed using linear contrasts of the coefficients from the overall model. Reliability across trials for a given device was assessed using intraclass correlation coefficients as estimated in the mixed model. The GPS watches demonstrated lower reliability (intraclass correlation coefficient) across trials when compared with the RT3, particularly at the higher speed, 7 km/hr. Three GPS watches (Forerunner, Polar, and Suunto) significantly and consistently underestimated EE compared with the reference EE given by the RT3 accelerometer (average mean difference: Garmin, -50.5%; Polar, -41.7%; and Suunto, -41.7%; all p < 0.001). Results suggested that caution should be exercised when using commercial GPS watches to estimate EE in athletes during field-based testing and training.
- Nadia B. Hassounah, ., Ray Nagle, ., Kathylynn Saboda, ., Denise J. Roe, ., Bruce L. Dalkin, ., & Kimberly M. McDermott, . (2013). Primary Cilia Are Lost in Preinvasive and Invasive Prostate Cancer. PLoS ONE, 8(7).
- Nelson-Moseke, A. C., Jeter, J. M., Cui, H., Roe, D. J., Chambers, S. K., & Laukaitis, C. M. (2013). An unusual BRCA mutation distribution in a high risk cancer genetics clinic. Familial cancer, 12(1).More infoThe Database of Individuals at High Risk for Breast, Ovarian, or Other Hereditary Cancers at the Arizona Cancer Center in Tucson, Arizona assesses cancer risk factors and outcomes in patients with a family history of cancer or a known genetic mutation. We analyzed the subset of clinic probands who carry deleterious BRCA gene mutations to identify factors that could explain why mutations in BRCA2 outnumber those in BRCA1. Medical, family, social, ethnic and genetic mutation histories were collected from consenting patients' electronic medical records. Differences between BRCA1 and BRCA2 probands from this database were analyzed for statistical significance and compared to published analyses. A significantly higher proportion of our clinic probands carry mutations in BRCA2 than BRCA1, compared with previous reports of mutation prevalence. This also holds true for the Hispanic sub-group. Probands with BRCA2 mutations were significantly more likely than their BRCA1 counterparts to present to the high risk clinic without a diagnosis of cancer. Other differences between the groups were not significant. Six previously unreported BRCA2 mutations appear in our clinic population. The increased proportion of probands carrying deleterious BRCA2 mutations is likely multifactorial, but may reflect aspects of Southern Arizona's unique ethnic heritage.
- Nobuko Hongu, ., Barron J. Orr, ., Denise J. Roe, ., Rebecca G. Reed, ., & Scott B. Going, . (2013). Global positioning system watches for estimating energy expenditure. Journal of Strength and Conditioning Research, 27(11), 3216-3220.
- Phipps-Yonas, H., Cui, H., Sebastiao, N., Brunhoeber, P. S., Haddock, E., Deymier, M. J., Klapper, W., Lybarger, L., Roe, D. J., & Hastings, K. T. (2013). Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma. Frontiers in immunology, 4.More infoThe major histocompatibility complex (MHC) class II-restricted antigen processing pathway presents antigenic peptides acquired in the endocytic route for the activation of CD4(+) T cells. Multiple cancers express MHC class II, which may influence the anti-tumor immune response and patient outcome. Low MHC class II expression is associated with poor survival in diffuse large B-cell lymphoma (DLBCL), the most common form of aggressive non-Hodgkin lymphoma. Therefore, we investigated whether gamma-interferon-inducible lysosomal thiol reductase (GILT), an upstream component of the MHC class II-restricted antigen processing pathway that is not regulated by the transcription factor class II transactivator, may be important in DLBCL biology. GILT reduces protein disulfide bonds in the endocytic compartment, exposing additional epitopes for binding to MHC class II and facilitating antigen presentation. In each of four independent gene expression profiling cohorts with a total of 585 DLBCL patients, low GILT expression was significantly associated with poor overall survival. In contrast, low expression of a classical MHC class II gene, HLA-DRA, was associated with poor survival in one of four cohorts. The association of low GILT expression with poor survival was independent of established clinical and molecular prognostic factors, the International Prognostic Index and the cell of origin classification, respectively. Immunohistochemical analysis of GILT expression in 96 DLBCL cases demonstrated variation in GILT protein expression within tumor cells which correlated strongly with GILT mRNA expression. These studies identify a novel association between GILT expression and clinical outcome in lymphoma. Our findings underscore the role of antigen processing in DLBCL and suggest that molecules targeting this pathway warrant investigation as potential therapeutics.
- Christina A. Cutshaw, ., Lisa K. Staten, ., Kerstin M. Reinschmidt, ., Christopher Davidson, ., & Denise J. Roe, . (2012). Depressive symptoms and health-related quality of life among participants in the pasos adelante chronic disease prevention and control program, Arizona, 2005-2008. Preventing Chronic Disease, 9(1).
- Linda K. Larkey, ., Patricia M. Herman, ., Denise J. Roe, ., Francisco Garcia, ., A.M. Lopez, ., J. Gonzalez, ., Prasadini N. Perera, ., & Kathylynn Saboda, . (2012). A cancer screening intervention for underserved Latina women by Lay Educators. Journal of Women's Health, 21(5), 557-566.
- Lisa K. Staten, ., Christina A. Cutshaw, ., Christopher Davidson, ., Kerstin Reinschmidt, ., Rosie Stewart, ., & Denise J. Roe, . (2012). Effectiveness of the pasos adelante chronic disease prevention and control program in a US-Mexico border community, 2005-2008. Preventing Chronic Disease, 9(1).
- Paloma I. Beamer, ., Christina A. Elish, ., Denise J. Roe, ., Miranda M. Loh, ., & David W. Layton, . (2012). Differences in metal concentration by particle size in house dust and soil. Journal of Environmental Monitoring, 14(3), 839-844.
- Patricia Thompson, ., Denise J. Roe, ., Liane Fales, ., Julie Buckmeier, ., Fang Wang, ., Stanley R. Hamilton, ., Achyut Bhattacharyya, ., Sylvan Green, ., Chiu-Hsieh Hsu, ., H.-H. Sherry Chow, ., Dennis J. Ahnen, ., C. Richard Boland, ., Russell I. Heigh, ., David E. Fay, ., Maria Elena Martinez, ., Elizabeth Jacobs, ., Erin L. Ashbeck, ., David S. Alberts, ., & Peter Lance, . (2012). Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. Cancer Prevention Research, 5(12), 1381-1393.
- Roe, D., Cutshaw, C. A., Staten, L. K., Reinschmidt, K. M., Davidson, C., & Roe, D. -. (2012). Depressive symptoms and health-related quality of life among participants in the Pasos Adelante chronic disease prevention and control program, Arizona, 2005-2008. Preventing chronic disease, 9.More infoChronic diseases are the leading causes of death in the United States and have been associated with depressive symptoms and poor health-related quality of life (HRQOL). This study examined whether depressive symptoms and HRQOL indicators changed among participants in Pasos Adelante, a chronic disease prevention and control program implemented in a US-Mexico border community.
- Liang-Chih Liu, ., Julie E. Lang, ., Ying Lu, ., Denise Roe, ., Shelley E. Hwang, ., Cheryl A. Ewing, ., Laura J. Esserman, ., Eugene Morita, ., Patrick Treseler, ., & Stanley P. Leong, . (2011). Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients. Cancer, 117(2), 250-258.
- Ursa Broum-Glaberman, ., Michelle Cordoba Kissee, ., Mary Lou Damiano, ., Denise J. Roe, ., & Alison T. Stopeck, . (2011). Decreased bone mineral density in adult patients with Hemophilia: Clinical significance, prevalence and risk factors. Journal of Coagulation Disorders, 3(1), 27-33.
- Wenqing Qi, ., Laurence S. Cooke, ., Xiaobing Liu, ., Lisa Rimsza, ., Denise J. Roe, ., Ann Manziolli. Daniel O. Persky, ., Thomas P. Miller, ., & Daruka Mahadevan, . (2011). Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma. Biochemical Pharmacology, 81(7), 881-890.
- Mary C. Clouser, ., Denise J. Roe, ., Janet A. Foote, ., Robin B. Harris, ., & David S. Alberts, . (2010). Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. Nutrition and Cancer, 62(8), 1058-1066.
- Setsuko K. Chambers, ., Mary C. Clouser, ., Amanda F. Baker, ., Denise J. Roe, ., Haiyan Cui, ., Molly A. Brewer, ., Kenneth D. Hatch, ., Michael S. Gordon, ., Mike F. Janicek, ., Jeffrey D. Isaacs, ., Alan N. Gordon, ., Raymond B. Nagle, ., Heather M. Wright, ., Janice L. Cohen, ., & David S. Alberts, . (2010). Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clinical Cancer Research, 16(21), 5320-5328.
- Betsy C. Wertheim, ., María Elena Martínez, ., Erin L. Ashbeck, ., Denise J. Roe, ., Elizabeth T. Jacobs, ., David S. Alberts, ., & Patricia A. Thompson, . (2009). Physical activity as a determinant of fecal bile acid levels. Cancer Epidemiology Biomarkers and Prevention, 18(5), 1591-1598.
- Ian F. Robey, ., Brenda K. Baggett, ., Nathaniel D. Kirkpatrick, ., Denise J. Roe, ., Julie Dosescu, ., Bonnie F. Sloane, ., Arig Ibrahim Hashini, ., David L. Morse, ., Natarajan Raghunand, ., Robert A. Gatenby, ., & Robert J. Gillies, . (2009). Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research, 69(6), 2260-2268.
- Janet A. Foote, ., James R. Ranger-Moore, ., Janine G. Einspahr, ., Kathylynn Saboda, ., Jaime Kenyon, ., James Warneke, ., Richard C. Miller, ., Rayna Goldman, ., Min-Jian Xu, ., Denise J. Roe, ., & David S. Alberts, . (2009). Chemoprevention of human actinic keratoses by topical DL-α-tocopherol. Cancer Prevention Research, 2(4), 394-400.
- M.A. Chisholm-Burns, ., C.A. Spivey, ., R. Rehfeld, ., M. Zawaideh, ., D.J. Roe, ., & R. Gruessner, . (2009). Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. American Journal of Transplantation, 9(11), 2497-2504.
- Mary C. Clouser, ., Denise J. Roe, ., Janet A. Foote, ., & Robin B. Harris, . (2009). Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial. Pharmacoepidemiology and Drug Safety, 18(4), 276-283.
- Patricia A. Thompson, ., Betsy C. Wertheim, ., Denise J. Roe, ., Erin L. Ashbeck, ., Elizabeth T. Jacobs, ., Peter Lance, ., María Elena Martínez, ., & David S. Alberts, . (2009). Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prevention Research, 2(12), 1023-1030.
- Claire C. Venker, ., James L. Goodwin, ., Denise J. Roe, ., Kristine L. Kaemingk, ., Shelagh Mulvaney, ., & Stuart F. Quan, . (2007). Normative psychomotor vigilance task performance in children ages 6 to 11 - The Tucson Children's Assessment of Sleep Apnea (TuCASA). Sleep and Breathing, 11(4), 217-224.
- Amanda F. Baker, ., Tomislav Dragovich, ., Wendy R. Tate, ., Ramesh K. Ramanathan, ., Denise Roe, ., Chiu-Hsieh Hsu, ., D. Lynn Kirkpatrick, ., & Garth Powis, . (2006). The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. Journal of Laboratory and Clinical Medicine, 147(2), 83-90.
- Frank G. Walter, ., Peter B. Chase, ., Miguel C. Fernandez, ., Diane Cameron, ., Denise J. Roe, ., & Mark Wolfson, . (2006). Pyridoxine does not prevent hyperbaric oxygen-induced seizures in rats. Journal of Emergency Medicine, 31(2), 135-138.
- Mary C. Clouser, ., Robin B. Harris, ., Denise J. Roe, ., Kathylynn Saboda, ., James Ranger-Moore, ., Laura Duckett, ., & David S. Alberts, . (2006). Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression. Cancer Epidemiology Biomarkers and Prevention, 15(11), 2292-2297.
- Alan List, ., Sandy Kurtin, ., Denise J. Roe, ., Andrew Buresh, ., Daruka Mahadevan, ., Deborah Fuchs, ., Lisa Rimsza, ., Ruth Heaton, ., Robert Knight, ., & Jerome B. Zeldis, . (2005). Efficacy of lenalidomide in myelodysplastic syndromes. New England Journal of Medicine, 352(6), 549-557.
- David S. Alberts, ., María Elena Martínez, ., Lisa M. Hess, ., Janine G. Einspahr, ., Sylvan B. Green, ., A.K. Bhattacharyya, ., Jose Guillen, ., Mary Krutzsch, ., Ashok K. Batta, ., Gerald Salen, ., Liane Fales, ., Kris Koonce, ., Dianne Parish, ., Mary Clouser, ., Denise Roe, ., & Peter Lance, . (2005). Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. Journal of the National Cancer Institute, 97(11), 846-853.
- Denise H. Frank, ., Denise J. Roe, ., H.-H. Sherry Chow, ., Jose M. Guillen, ., Karin Choquette, ., Debra Gracie, ., Jennifer Francis, ., Airley Fish, ., & David S. Alberts, . (2004). Effects of a High-Selenium Yeast Supplement on Celecoxib Plasma Levels: A Randomized Phase II Trial. Cancer Epidemiology Biomarkers and Prevention, 13(2), 299-303.
- Elizabeth T. Jacobs, ., Anna R. Giuliano, ., Denise J. Roe, ., José M. Guillén-Rodríguez, ., Vernon L. Hartz, ., Robin C. Whitacre, ., David S. Alberts, ., & María Elena Martínez, . (2004). Dietary change in an intervention trial of wheat bran fiber and colorectal adenoma recurrence. Annals of Epidemiology, 14(4), 280-286.
- Erin M. Siegel, ., Neal E. Craft, ., Denise J. Roe, ., Eliane Duarte-Franco, ., Luisa L. Villa, ., Eduardo L. Franco, ., & Anna R. Giuliano, . (2004). Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from brazilian women. Cancer Epidemiology Biomarkers and Prevention, 13(11), 1693-1703.
- Zhao Chen, ., William A. Stini, ., James R. Marshall, ., Maria Elena Martínez, ., Jose. M. Guillén-Rodríguez, ., Denise Roe, ., & David S. Alberts, . (2004). Wheat bran fiber supplementation and bone loss among older people. Nutrition, 20(9), 747-751.
- Anna R. Giuliano, ., Erin M. Siegel, ., Denise J. Roe, ., Silvandeiede Ferreira, ., Maria Luiza Baggio, ., Lenice Galan, ., Eliane Duarte-Franco, ., Luisa L. Villa, ., Thomas E. Rohan, ., James R. Marshall, ., & Eduardo L. Franco, . (2003). Dietary Intake and Risk of Persistent Human Papillomavirus (HPV) Infection: The Ludwig-McGill HPV Natural History Study. Journal of Infectious Diseases, 188(10), 1508-1516.
- David S. Alberts, ., Janine G. Einspahr, ., David L. Earnest, ., Mary F. Krutzsch, ., Po Lin, ., Lisa M. Hess, ., David K. Heddens, ., Denise J. Roe, ., Maria Elena Martínez, ., Gerald Salen, ., & A.K. Batta, . (2003). Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial. Cancer Epidemiology Biomarkers and Prevention, 12(3), 197-200.
- Graham Nichol, ., T. Valenzuela, ., D. Roe, ., L. Clark, ., E. Huszti, ., & G.A. Wells, . (2003). Cost effectiveness of defibrillation by targeted responders in public settings. Circulation, 108(6), 697-703.
- Mary E. Reid, ., James R. Marshall, ., Denise Roe, ., Michael Lebowitz, ., David Alberts, ., Achyut K. Battacharyya, ., & Maria Elena Martinez, . (2003). Smoking Exposure as a Risk Factor for Prevalent and Recurrent Colorectal Adenomas. Cancer Epidemiology Biomarkers and Prevention, 12(10), 1006-1011.
- Anna R. Giuliano, ., Rebecca L. Sedjo, ., Denise J. Roe, ., Robin Harris, ., Susie Baldwin, ., Mary R. Papenfuss, ., Martha Abrahamsen, ., & Paula Inserra, . (2002). Clearance of oncogenic human papillomavirus (HPV) infection: Effect of smoking (United States). Cancer Causes and Control, 13(9), 839-846.
- Anna R. Giuliano, ., Robin Harris, ., Rebecca L. Sedjo, ., Susie Baldwin, ., Denise Roe, ., Mary R. Papenfuss, ., Martha Abrahamsen, ., Paula Inserra, ., Sandra Olvera, ., & Kenneth Hatch, . (2002). Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. Journal of Infectious Diseases, 186(4), 462-469.
- David Heddens, ., David S. Alberts, ., Edward V. Hannigan, ., Steven D. Williams, ., Dava Garcia, ., Denise J. Roe, ., Jeffrey Bell, ., & Ronald D. Alvarez, . (2002). Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment. Gynecologic Oncology, 86(3), 239-243.
- Elizabeth T. Jacobs, ., Anna R. Giuliano, ., Denise J. Roe, ., José M. Guillén-Rodríguez, ., David S. Alberts, ., & María Elena Martínez, . (2002). Baseline dietary fiber intake and colorectal adenoma recurrence in the wheat bran fiber randomized trial. Journal of the National Cancer Institute, 94(21), 1620-1625.
- Elizabeth T. Jacobs, ., Anna R. Giuliano, ., Denise J. Roe, ., José M. Guillén-Rodríguez, ., Lisa M. Hess, ., David S. Alberts, ., & María Elena Martínez, . (2002). Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial. Cancer Epidemiology Biomarkers and Prevention, 11(9), 906-914.
- Harris Bernstein, ., Hana Holubec, ., James A. Warneke, ., Harinder Garewal, ., David L. Earnest, ., Claire M. Payne, ., Denise J. Roe, ., Haiyan Cui, ., Elaine L. Jacobson, ., & Carol Bernstein, . (2002). Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients. Annals of Surgical Oncology, 9(5), 505-517.
- Rebecca L. Sedjo, ., Denise J. Roe, ., Martha Abrahamsen, ., Robin B. Harris, ., Neal Craft, ., Susie Baldwin, ., & Anna R. Giuliano, . (2002). Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiology Biomarkers and Prevention, 11(9), 876-884.
- Rebecca L. Sedjo, ., Paula Inserra, ., Martha Abrahamsen, ., Robin B. Harris, ., Denise J. Roe, ., Susie Baldwin, ., & Anna R. Giuliano, . (2002). Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiology Biomarkers and Prevention, 11(4), 353-359.
- Janet A. Foote, ., Robin B. Harris, ., Anna R. Giuliano, ., Denise J. Roe, ., Thomas E. Moon, ., Brenda Cartmel, ., & David S. Alberts, . (2001). Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. International Journal of Cancer, 95(1), 7-11.
- R. Dorr, ., C. Karanes, ., C. Spier, ., T. Grogan, ., J. Greer, ., J. Moore, ., B. Weinberger, ., G. Schiller, ., T. Pearce, ., M. Litchman, ., W. Dalton, ., D. Roe, ., & A.F. List, . (2001). Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia. Journal of Clinical Oncology, 19(6), 1589-1599.
- Anabel L. Hill, ., Denise J. Roe, ., Douglas L. Taren, ., Myra M. Muramoto, ., & Scott J. Leischow, . (2000). Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Nicotine and Tobacco Research, 2(3), 247-253.
- Antonio T. Baines, ., Hanna Holubec, ., Jenny L. Basye, ., Patricia Thorne, ., Achyut K. Bhattacharyya, ., Julian Spallholz, ., Brent Shriver, ., Haiyan Cui, ., Denise Roe, ., Larry C. Clark, ., David L. Earnest, ., & Mark A Nelson, . (2000). The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts. Cancer Letters, 160(2), 193-198.
- C.L. Crowley, ., C.M. Payne, ., H. Bernstein, ., C. Bernstein, ., & D. Roe, . (2000). The NAD + precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death and Differentiation, 7(3), 314-326.
- D.S. Alberts, ., R.T. Dorr, ., J.G. Einspahr, ., M. Aickin, ., K. Saboda, ., M.J. Xu, ., Y.-M. Peng, ., R. Goldman, ., J.A. Foote, ., J.A. Warneke, ., S. Salasche, ., D.J. Roe, ., & G.T. Bowden, . (2000). Chemoprevention of human actinic keratoses by topical 2-(Difluoromethyl)-dl-ornithine. Cancer Epidemiology Biomarkers and Prevention, 9(12), 1281-1286.
- David S. Alberts, ., María Elena Martínez, ., Denise J. Roe, ., José M. Guillén-Rodríguez, ., James R. Marshall, ., J. Barbara Van Leeuwen, ., Mary E. Reid, ., Cheryl Ritenbaugh, ., Perla A. Vargas, ., A.B. Bhattacharyya, ., David L. Earnest, ., Richard E. Sampliner, ., Dianne Parish, ., Kris Koonce, ., & Lianne Fales, . (2000). Erratum: Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas (New England Journal of Medicine (April 20, 2000) 342 (1156-1162)). New England Journal of Medicine, 343(13), 980.
- David S. Alberts, ., María Elena Martínez, ., Denise J. Roe, ., José M. Guillén-Rodríguez, ., James R. Marshall, ., J. Barbara Van Leeuwen, ., Mary E. Reid, ., Cheryl Ritenbaugh, ., Perla A. Vargas, ., A.B. Bhattacharyya, ., David L. Earnest, ., Richard E. Sampliner, ., Dianne Parish, ., Kris Koonce, ., & Lianne Fales, . (2000). Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. New England Journal of Medicine, 342(16), 1156-1162.
- H.-H. Sherry Chow, ., David L. Earnest, ., David Clark, ., Nancy Mason-Liddil, ., Cheryl B. Kramer, ., Janine G. Einspahr, ., Jose M. Guillen-Rodriguez, ., Denise J. Roe, ., Winfred Malone, ., James A. Crowell, ., & David S. Alberts, . (2000). Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E 2 levels in healthy subjects with a history of resected polyps. Cancer Epidemiology Biomarkers and Prevention, 9(4), 351-356.
- Mark A Nelson, ., Michael D Radmacher, ., Richard Simon, ., Mikel Aickin, ., Jin-Ming Yang, ., Lita Panda, ., Julia Emerson, ., Denise Roe, ., Lawrence Adair, ., Floyd Thompson, ., Jerry Bangert, ., Stanley P.L Leong, ., Raymond Taetle, ., Sydney Salmon, ., & Jeffrey Trent, . (2000). Chromosome abnormalities in malignant melanoma: Clinical significance of nonrandom chromosome abnormalities in 206 cases. Cancer Genetics and Cytogenetics, 122(2), 101-109.
- R. Calaluce, ., D.L. Earnest, ., D. Heddens, ., J.G. Einspahr, ., D. Roe, ., C.L. Bogert, ., J.R. Marshall, ., & D.S. Alberts, . (2000). Effects of piroxicam on prostaglandin E 2 levels in rectal mucosa of adenomatous polyp patients: A randomized phase IIb trial 1. Cancer Epidemiology Biomarkers and Prevention, 9(12), 1287-1292.
- Terence D. Valenzuela, ., Denise J. Roe, ., Graham Nichol, ., Lani L. Clark, ., Daniel W. Spaite, ., & Richard G. Hardman, . (2000). Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. New England Journal of Medicine, 343(17), 1206-1209.
- B. Risendal, ., D. Roe, ., J. DeZapien, ., M. Papenfuss, ., & A. Giuliano, . (1999). Influence of health care, cost, and culture on breast cancer screening: Issues facing urban American Indian women. Preventive Medicine, 29(6 I), 501-509.
- Carol Bernstein, ., Harris Bernstein, ., Harinder Garewal, ., Pat Dinning, ., Rawah Jabi, ., Richard E. Sampliner, ., Margaret K. McCuskey, ., Madhulita Panda, ., Denise J Roe, ., Lawrence L'Heureux, ., & Claire Payne, . (1999). A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Research, 59(10), 2353-2357.
- David L. Earnest, ., Richard E. Sampliner, ., Denise J. Roe, ., Barbara Van Leeuwen, ., Jose Guillen, ., Mary Reid, ., Maria Elena Martinez, ., James R. Marshall, ., & David S. Alberts, . (1999). Progress report: The Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps. American Journal of Medicine, 106(1 A), 43S-45S.
- María Elena Martínez, ., David Heddens, ., David L. Earnest, ., Cheryl L. Bogert, ., Denise Roe, ., Janine Einspahr, ., James R. Marshall, ., & David S. Alberts, . (1999). Physical activity, body mass index, and prostaglandin E 2 levels in rectal mucosa. Journal of the National Cancer Institute, 91(11), 950-953.
- N. Raghunand, ., X. He, ., R. Van Sluis, ., B. Mahoney, ., B. Baggett, ., C.W. Taylor, ., G. Paine-Murrieta, ., D. Roe, ., Z.M. Bhujwalla, ., & R.J. Gillies, . (1999). Enhancement of chemotherapy by manipulation of tumour pH. British Journal of Cancer, 80(7), 1005-1011.
- Raymond Taetle, ., Mikel Aickin, ., Jin-Ming Yang, ., Lita Panda, ., Julia Emerson, ., Denise Roe, ., Lawrence Adair, ., Floyd Thompson, ., Yun Liu, ., Lee Wisner, ., John R. Davis, ., Jeffrey Trent, ., & David S. Alberts, . (1999). Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes and Cancer, 25(3), 290-300.
- Raymond Taetle, ., Mikel Aickin, ., Lita Panda, ., Julia Emerson, ., Roe Denise, ., Floyd Thompson, ., John Davis, ., Jeffrey Trent, ., & David Alberts, . (1999). Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Genes Chromosomes and Cancer, 25(1), 46-52.
- A. Hill, ., D. Taren, ., D. Roe, ., T. Lohman, ., & S. Leischow, . (1998). Body composition changes in hispanics after smoking cessation. FASEB Journal, 12(5), A862.
- Claire Redman, ., Julie A. Scott, ., Antonio T. Baines, ., Jenny L. Basye, ., Larry C. Clark, ., Cindy Calley, ., Denise Roe, ., Claire M. Payne, ., & Mark A. Nelson, . (1998). Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Letters, 125(1-2), 103-110.
- F.G. Walter, ., R.L. Gibly, ., R.K. Knopp, ., & D.J. Roe, . (1998). Squamous cells as predictors of bacterial contamination in urine samples. Annals of Emergency Medicine, 31(4), 455-458.
- Yei-Mei Peng, ., Yeh-Shan Peng, ., Joel M. Childers, ., Kenneth D. Hatch, ., Denise J. Roe, ., Yonggu Lin, ., & Po Lin, . (1998). Concentrations of carotenoids, tocopherols, and retinol in paired plasma and cervical tissue of patients with cervical cancer, precancer, and noncancerous diseases. Cancer Epidemiology Biomarkers and Prevention, 7(4), 347-350.
- Denise J. Roe, . (1997). Comparison of population pharmacokinetic modeling methods using simulated data: Results from the Population Modeling Workgroup. Statistics in Medicine, 16(11), 1241-1262.
- Denise J. Roe, ., & Michael D. Karol, . (1997). Averaging pharmacokinetic parameter estimates from experimental studies: Statistical theory and application. Journal of Pharmaceutical Sciences, 86(5), 621-624.
- Hsiao-Hui Chow, ., Kristin M. Tolle, ., Denise J. Roe, ., Victor Elsberry, ., & Hsinchun Chen, . (1997). Application of neural networks to population pharmacokinetic data analysis. Journal of Pharmaceutical Sciences, 86(7), 840-845.
- Pamela J. Kling, ., Tara M. Sullivan, ., Margaret E. Leftwich, ., & Denise J. Roe, . (1997). Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants. Archives of Pediatrics and Adolescent Medicine, 151(1), 27-31.
- Terence D. Valenzuela, ., Denise J. Roe, ., Shan Cretin, ., Daniel W. Spaite, ., & Mary P. Larsen, . (1997). Estimating effectiveness of cardiac arrest interventions: A logistic regression survival model. Circulation, 96(10), 3308-3313.
- Alan F. List, ., Catherine S. Spier, ., Thomas M. Grogan, ., Cynthia Johnson, ., Denise J. Roe, ., John P. Greer, ., Steven N. Wolff, ., Henricus J. Broxterman, ., George L. Scheffer, ., Rik J. Scheper, ., & William S. Dalton, . (1996). Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87(6), 2464-2469.
- Denise J. Roe, ., Antonia M. Harford, ., Philip G. Zager, ., Thomas B. Wiltbank, ., Linda Kirlin, ., Ann Marie Della Valle, ., & David B. Van Wyck, . (1996). Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: A prospective analysis and comparison of two agents. American Journal of Kidney Diseases, 28(6), 855-860.
- Denise J. Roe, ., David S. Alberts, ., Michael J. Wargovich, ., Roberd M. Bostick, ., Harinder S. Garewal, ., Janine Einspahr, ., Lisa Fosdick, ., Lois Ramsey, ., Cynthia Woods, ., & Daniel L. McGee, . (1996). Reproducibility of the measurement of colonic proliferation using bromodeoxyuridine across laboratories. Cancer Epidemiology Biomarkers and Prevention, 5(5), 349-353.
- Guido Tricot, ., David S. Alberts, ., Cynthia Johnson, ., Denise J. Roe, ., Robert T. Dorr, ., Dwayne Bracy, ., David H. Vesole, ., Sundar Jagannath, ., Ross Meyers, ., & Bart Barlogie, . (1996). Safety of autotransplants with high-dose melphalan in renal failure: A pharmacokinetic and toxicity study. Clinical Cancer Research, 2(6), 947-952.
- J. Einspahr, ., D. Alberts, ., T. Xie, ., J. Ritchie, ., D. Earnest, ., L. Hixson, ., M. Powell, ., D. Roe, ., & T. Grogan, . (1995). Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls. Cancer Epidemiology Biomarkers and Prevention, 4(4), 359-366.
- Y.-M. Peng, ., Y.-S. Peng, ., Y. Lin, ., T. Moon, ., D.J. Roe, ., & C. Ritenbaugh, . (1995). Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutrition and Cancer, 23(3), 233-246.
- D.S. Alberts, ., J. Einspahr, ., M. Aickin, ., L. Hixson, ., D. Earnest, ., D. Roe, ., & M. Powell, . (1994). Validation of proliferation indices as surrogate endpoint biomarkers. Journal of Cellular Biochemistry, 56(SUPPL. 19), 76-83.
- D.J. Roe, ., & E.L. Korn, . (1993). Time-period effects in longitudinal studies measuring average rates of change. Statistics in Medicine, 12(9), 893-900.
- C.W. Taylor, ., D.S. Alberts, ., Y.-M. Peng, ., T.M. McCloskey, ., M. Matzner, ., D.J. Roe, ., P.M. Plezia, ., G.B. Grindey, ., M. Hamilton, ., & D. Seitz, . (1992). Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer. Journal of the National Cancer Institute, 84(23), 1798-1802.
- C.W. Taylor, ., W.S. Dalton, ., P.R. Parrish, ., M.C. Gleason, ., W.T. Bellamy, ., F.H. Thompson, ., D.J. Roe, ., & J.M. Trent, . (1991). Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. British Journal of Cancer, 63(6), 923-929.
- D.S. Alberts, ., N. Mason-Liddil, ., P.M. Plezia, ., D.J. Roe, ., R.T. Dorr, ., R.F. Struck, ., & J.G. Phillips, . (1991). Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: A placebo-controlled clinical trial. Journal of the National Cancer Institute, 83(23), 1739-1743.
- G.J. Shamdas, ., H.S. Garewal, ., & D.J. Roe, . (1991). Usefulness of bone-marrow biopsy during induction therapy for acute myeloid leukaemia . Lancet, 339(8786), 178.
- M. Lehnert, ., W.S. Dalton, ., D. Roe, ., S. Emerson, ., & S.E. Salmon, . (1991). Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model. Blood, 77(2), 348-354.
- S.E. Salmon, ., W.S. Dalton, ., T.M. Grogan, ., P. Plezia, ., M. Lehnert, ., D.J. Roe, ., & T.P. Miller, . (1991). Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer. Blood, 78(1), 44-50.
- M.M. Webber, ., A.S. Gomes, ., D. Roe, ., R.L. La Fontaine, ., & R.A. Hawkins, . (1990). Comparison of Biello, McNeil, and PIOPED criteria for the diagnosis of pulmonary emboli on lung scans. American Journal of Roentgenology, 154(5), 975-981.
- P. Scuderi, ., P.R. Finley, ., B.Y. Shon, ., J.N. Udall, ., D.J. Roe, ., & A.S.-F. Chong, . (1990). Regulation of tumor necrosis factor secretion in leukocytes from alpha-1-antitrypsin deficient humans. Immunological Investigations, 19(5), 453-461.
- P.M. Plezia, ., D.S. Alberts, ., J.F. Kessler, ., P.L. Berens, ., J.L. Chase, ., & D.J. Roe, . (1990). Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen. Journal of Pain and Symptom Management, 5(2), 101-108.
- Patricia M. Plezia, ., David S. Alberts, ., John F. Kessler, ., Patricia L. Berens, ., Judy L. Chase, ., & Denise J. Roe, . (1990). Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen. Journal of Nurse-Midwifery, 5(2), 101-108.
- C.W. Taylor, ., D.S. Alberts, ., M.A. Ketcham, ., W.G. Satterlee, ., M.T. Holdsworth, ., P.M. Plezia, ., Y.-M. Peng, ., T.M. McCloskey, ., D.J. Roe, ., M. Hamilton, ., & S.E. Salmon, . (1989). Clinical pharmacology of a novel diarylsulfonylurea anticancer agent. Journal of Clinical Oncology, 7(11), 1733-1740.
- C. Kimme-Smith, ., S.T. Cochran, ., & D.J. Roe, . (1988). Medical pattern recognition pitfalls in a clinical setting: Renal cell carcinoma survival prediction. Medical Physics, 15(3), 401-406.
- D.S. Alberts, ., E.A. Surwit, ., Y.-M. Pen, ., T. McCloskey, ., R. Rivest, ., V. Graham, ., L. McDonald, ., & D. Roe, . (1988). Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration. Cancer Research, 48(20), 5874-5877.
- F.K. Storm, ., R.M. Elashoff, ., H.W. Baker, ., E.F. Scanlon, ., B. Drury, ., M. Lee, ., D. Roe, ., & D.L. Morton, . (1988). Thermal dose-response of magnetic-induction thermoradiotherapy. Journal of Surgical Oncology, 39(2), 79-83.
- H.S. Garewal, ., E.W. Gerner, ., R.E. Sampliner, ., & D. Roe, . (1988). Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus. Cancer Research, 48(11), 3288-3291.
- L.E. Davis, ., D.S. Alberts, ., P.M. Plezia, ., D.J. Roe, ., & D.P. Griswold, . (1988). Predictive model for plasma concentration-versus-time profiles of investigational anticancer drugs in patients. Journal of the National Cancer Institute, 80(11), 815-819.
- C. Kimme-Smith, ., L.W. Bassett, ., R.H. Gold, ., D. Roe, ., & J. Orr, . (1987). Mammographic dual-screen-dual-emulsion-film combination: Visibility of simulated microcalcifications and effect on image contrast. Radiology, 165(2), 313-318.
- F.K. Storm, ., E.F. Scanlon, ., H.W. Baker, ., D. Roe, ., & D.L. Morton, . (1987). Tumor stabilization after hyperthermia: An important criterion of response to thermal therapy. Journal of Surgical Oncology, 34(3), 143-149.
- L.A. Cagle, ., J.M. Mirra, ., F.K. Storm, ., D.J. Roe, ., & F.R. Eilber, . (1987). Histologic features relating to prognosis in synovial sarcoma. Cancer, 59(10), 1810-1814.
- R.F. Struck, ., D.S. Alberts, ., K. Horne, ., J.G. Phillips, ., Y.M. Peng, ., & D.J. Roe, . (1987). Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial. Cancer Research, 47(10), 2723-2726.
- A. Norman, ., D. Bass, ., & D. Roe, . (1985). Screening human populations for chromosome aberrations. Mutation Research, 143(3), 155-160.
- F.K. Storm, ., D.A. Christensen, ., A.J. Olch, ., A.W. Silberman, ., D.J. Roe, ., W.H. Harrison, ., R.S. Elliott, ., & D.L. Morton, . (1985). Variability of heating patterns in animals by magnetic induction hyperthermia. Journal of Surgical Oncology, 29(2), 82-88.
- F.K. Storm, ., H.W. Baker, ., E.F. Scanlon, ., H.P. Plenk, ., P.M. Meadows, ., S.C. Cohen, ., C.E. Olson, ., J.W. Thomson, ., J.D. Khandekar, ., & D. Roe, . (1985). Magnetic-induction hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients. Cancer, 55(11), 2677-2687.
- A. Norman, ., S. Cochran, ., D. Bass, ., & D. Roe, . (1984). Effects of age, sex and diagnostic X-rays on chromosome damage. International Journal of Radiation Biology, 46(3), 317-321.
- A.S. Gomes, ., A.R. Sinaiko, ., L. Tobian, ., J.N. Cohn, ., A.G. Formanek, ., D.J. Roe, ., & K. Amplatz, . (1984). Renal vein renin sampling in essential hypertension using hydralazine and the tourniquet test. Radiology, 153(3 I), 619-623.
- Carl A. Bertelsen, ., Armando E. Giuliano, ., David H. Kern, ., Barry D. Mann, ., Denise J. Roe, ., & Donald L. Morton, . (1984). Breast cancers: Estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response. Journal of Surgical Research, 37(4), 257-263.
- F.Kristian Storm, ., Denise J. Roe, ., Susanne Hildebrand-Zanki, ., Gloria D. Worth, ., Donald L. Morton, ., & David H. Kern, . (1983). Natural thermal resistance of human tumor cells and the role of prostaglandin. Surgery, 94(2), 376-383.
- S.T. Cochran, ., W.S. Wong, ., & D.J. Roe, . (1983). Predicting angiography- induced acute renal function impairment: Clinical risk model. American Journal of Roentgenology, 141(5), 1027-1033.
- C. Callery, ., A.J. Cochran, ., D.J. Roe, ., W. Rees, ., S.D. Nathanson, ., J.K. Benedetti, ., R.M. Elashoff, ., & D.L. Morton, . (1982). Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Annals of Surgery, 196(1), 69-75.
- S.S. Ahn, ., R.F. Irie, ., T.H. Weisenburger, ., P.C. Jones, ., G. Juillard, ., D.J. Roe, ., & D.L. Morton, . (1982). Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: Correlation with clinical response. Surgery, 92(2), 362-367.
- Ussery, C., Hingle, M. D., Going, S. B., Merchant, N. C., Roe, D., Stump, C. S., Kutob, R. M., Kutob, R. M., Stump, C. S., Roe, D., Merchant, N. C., Going, S. B., Ussery, C., & Hingle, M. D. (2016, April 6). Metabolic Risk Factor Prevalence in Children Participating in a Family-Based Community Diabetes Prevention Program. In Experimental Biology Conference.
- Tate, T., Baggett, B., Rice, P., Watson, J., Orsinger, G., Nymeyer, A. C., Welge, W. A., Keenan, M., Saboda, K., Roe, D. J., Hatch, K., Chambers, S., Black, J., Utzinger, U., Barton, J., MahadevanJansen, A., VoDinh, T., & Grundfest, W. (2015, 2015). Multispectral fluorescence imaging of human ovarian and Fallopian tube tissue for early stage cancer detection. In Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XIII, 9313.
- Patanwala, A. E., Erstad, B. L., Roe, D., & Sakles, J. C. (2015, October). Succinylcholine is associated with increased mortality when used for rapid sequence intubation of severely head injured patients in the emergency department. ACEP Research Forum. Boston, MA.
- Hongu, N. -., Pope, B. T., Martinez, C. L., Merchant, N. C., Misner, S. L., & Roe, D. -. (2013, April). Using smartphones to maintain engagement of youth participation in 8-week walking program. Experimental Biology. Boston, MA: American Society for Nutrition.
- Chow, H., Algotar, A., Altbach, M. I., Galons, J., Roe, D., Thomson, C. A., Guillen-Rodriguez, J. M., Martinez, J. A., Chalasani, P., Villa Guillen, D. E., Tapia, E. O., & Trujillo, J. (2018, Fall). Abstract: Phase II clinical study of metformin for breast cancer prevention. UACC Scientific Retreat. UACC Scientific Retreat. Tucson, AZ.
- Chow, H., Algotar, A., Roe, D., Miller, J., Gallons, J. P., Altbach, M., Thomson, C. A., Chalasani, P., Cordova, C., Tapia, E., Villa-Guillen, D. E., & Trujillo, J. S. (2018, March 2018). The potential for metformin to reduce obesity-associated breast cancer risk. American Society for Preventive Oncology, 42nd Annual Conference. New York: American Society for Preventive Oncology.
- Hastings, K. T., DiCaudo, D. J., Roe, D., Cui, H., Meador, L. R., & Menon, H. (2017, May). Inducers of GILT expression in human melanoma. Society for Investigative Dermatology Annual Meeting. Portland, OR.
- Hastings, K. T., Homsi, J., Roe, D., Cui, H., Thomson, N., Menon, H., & Meador, L. R. (2017, March). Evaluating the association of GILT expression with patient outcome in metastatic melanoma. 2nd Annual Arizona Biomedical Research Commission Research Conference. Phoenix, AZ.
- Hastings, K. T., Homsi, J., Roe, D., Cui, H., Thomson, N., Menon, H., & Meador, L. R. (2017, March). Evaluating the association of GILT expression with patient outcome in metastatic melanoma. AZBio Expo in partnership with National Institue of Collaborative Healthcare. Tempe, AZ.
- Patanwala, A. E., Erstad, B. L., Roe, D., & Sakles, J. C. (2015, October). Succinylcholine is associated with increased mortality when used for rapid sequence intubation of severely head injured patients in the emergency department. American College of Emergency Physicians. Boston, MA.
- Turner, T., Kutob, R. M., Going, S. B., Merchant, N. C., Roe, D., Stump, C., & Hingle, M. D. (2014, November). E.P.I.C. Kids study: a family-focused community program to prevent type 2 diabetes in youth. The University of Arizona CALS 2014 Research Forum. University of Arizona: College of Agriculture and Life Sciences.More infoThe University of Arizona CALS 2014 Research Forum. E.P.I.C. Kids study: a family-focused community program to prevent type 2 diabetes in youth. T Turner* (presenting author), R Kutob, S Going, N Merchant, D Roe, C Stump, M Hingle
- Hingle, M., Going, S. B., Orr, B. J., Hongu, N. -., Merchant, N., Nichter, M. -., Roe, D. -., Borden, L., Astroth, K. A., & Marsh, S. E. (2013, August). Stealth health: Youth innovation, mobile technology, online social networking, and informal learning to promote physical activity. Society for Nutrition Education and Behavior, Annual Conference. Portland, OR.: Society for Nutrition Education and Behavior.
- Hongu, N. -., Roe, D. -., Byrd-Bredbenner, C., Worobey, J., Martin-Biggers, J., & Hernandez, G. (2013, April). HomeStyles: Shaping home environments and lifestyle practices to prevent childhood obesity: A randomized controlled trial.. Priester National Health Extension Conference, Corvallis, OR. Corvallis, OR.
- Sardo, C. L., Thomson, C. A., Hibler, E. A., Harris, R. B., Roe, D. R., Greenlee, H., Lance, M. P., Thompson, P., & Jacobs, E. T. (2013, November). Berry consumption and colorectal adenoma recurrence: a pooled analysis. American Institute for Cancer Research. Washington, DC.